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ABSTRACT 
 Drug-associated stimuli trigger craving and relapse in addiction. Murine morphine 
conditioned place preference (CPP) was used to model learning of opioid associations. We 
examined how morphine and learning interact to alter neuron morphology in the nucleus 
accumbens (NAc) core and shell after acquisition and extinction of CPP. Conditioning with 
morphine dose-dependently increased place preference compared to saline. In comparison 
to those from saline conditioned and morphine non-conditioned controls, neurons from the 
NAc core of morphine conditioned mice had increased dendritic complexity, as defined by 
increased dendritic length, number, and Sholl intersections. This effect is due to the 
combination of morphine and learning, which is different from effects of morphine or 
conditioning alone. Morphine administration without conditioning was associated with 
increased spine density in the core, which was reversed by CPP acquisition. Control 
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conditioning with saline produced no morphology changes. Morphine CPP extinction was 
associated with decreased dendritic complexity, reversing the increased complexity seen 
after acquisition. Mice that extinguished CPP had similar dendritic complexity to saline 
conditioned mice, in terms of dendritic count and intersections, but less dendritic 
complexity than non-extinguished mice that retained CPP. Since dopamine release imbues 
salience to stimuli that coincide with drug use, and the dopamine D1 receptor mediates 
CPP acquisition, we tested the effect of SKF81297 D1 receptor agonist on CPP extinction 
and associated accumbal neuron morphology. SKF81297 (0.8 mg/kg) injected after each 
extinction training session impeded extinction, and produced increased dendritic 
complexity compared to controls. SKF81297 may have sustained conditioned associations, 
disrupted consolidation of extinction, and/or disrupted the decline in dopamine levels that 
may occur throughout extinction sessions. We hypothesize that changes occurred in the 
NAc core because this region mediates how stimuli and drug effects direct motor action. 
Since D1 receptors oppose extinction of drug-cue-induced behavior, they play a role in 
reinforcing opioid addiction. Acquisition and extinction may be opposite processes in the 
brain, as in behavior. Extinction may include some reversal of acquisition learning as well 
as being new learning with its own pathway. Interventions that target D1 receptors or that 
selectively reduce NAc core dendritic complexity may contribute to opioid addiction 
treatment. 
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Chapter 1: Introduction 
Table 1: Impact of This Work 
State of Field Before This Work State of Field After This Work 
Chronic morphine followed by multiple 
days withdrawal = decreased dendritic 
complexity and spine density of NAc shell 
neurons 
Short term morphine followed by one day 
withdrawal = increased spine density of 
NAc core neurons 
Cocaine CPP is correlated with increased 
spine density in the NAc core and shell 
Morphine CPP is correlated with 
increased dendritic complexity in the NAc 
core 
Unknown what morphology is associated 
with CPP extinction 
Morphine CPP extinction is associated 
with reversal of increased dendritic 
complexity in the NAc core 
D1 antagonist SCH23390 can impede 
cocaine CPP extinction 
D1 agonist SKF81297 can impede 
morphine CPP extinction 
D1 activation in vitro can increase spine 
density and dendritic complexity of 
striatal neurons. 
D1 agonist SKF81297-induced impedance 
of morphine CPP extinction protects 
increased dendritic complexity in the NAc 
core, and is associated with increased 
spine density   
 
Significance  
At least 2 million Americans abuse opioids, making them the most 
commonly abused prescription drug (“Painkillers Fuel,” 2011). Opioid abuse produces 
tremendous morbidity, and the annual cost to society is over $55.7 billion (Birnbaum, et 
al., 2011). The worst outcome of opioid misuse is overdose resulting in death, largely from 
respiratory depression. The problem has rapidly intensified, as opioid abuse tripled from 
1991-2001 (“Painkillers Fuel,” 2011) and mortality rates were up over 100% from 1999-
2007 (Maxwell, 2011), with a recent spike in heroin-related deaths since 2010 (Hedegaard, 
Chen, & Warner, 2015). 
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Opioid Receptor Signaling 
 Opioids are ligands of the seven-transmembrane opioid receptors that are 
mainly coupled to G-proteins for intracellular signaling. There are four types of receptors: 
δ opioid receptors (DOR), μ opioid receptors (MOR), κ opioid receptors (KOR), and the 
less well-characterized opioid receptor-like orphan (ORL) receptors (Feng, et al., 2012). 
When a δ, μ, or κ opioid receptor is activated, guanosine-5’-triphosphate (GTP) replaces 
guanosine-5’-diphosphate (GDP) on the coupled G protein, causing its disassociation into 
functional Gα and Gβγ subunits (Bruchas & Chavkin, 2010).  Often, the alpha subunit is a 
G inhibitory (Gi) protein, which reduces levels of cyclic adenosine monophosphate 
(cAMP) by inhibiting adenylate cyclase. Protein kinase A (PKA) is usually activated by 
cAMP, so without it, there is reduced PKA activity. PKA normally phosphorylates and 
activates cAMP response element binding protein (CREB) and the α-Amino-3-hydroxy-5-
methyl-4-isoxazolepropionic acid glutamate receptor (AMPAR), affecting gene 
transcription and excitatory transmission (Chartoff & Connery, 2014). The Gβγ subunit 
goes on to activate G protein-gated inwardly rectifying potassium channels, causing 
hyperpolarization, and to inhibit voltage-gated calcium channels, preventing release of 
neurotransmitters by blocking entry of calcium into the cell (Connor & Christie, 1999). 
There are probably other opioid receptor signaling mechanisms, but the most established 
mechanisms show that opioids have an overall inhibitory effect on the neurons they 
encounter. 
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Opioid Receptor Distribution in the Brain and Neuron 
 MOR, DOR, and KOR are expressed throughout the rodent brain, excepting 
the cerebellum. Importantly, they are highly expressed in the mesocorticolimbic brain 
reward system. The nucleus accumbens (NAc), ventral tegmental area (VTA), prefrontal 
cortex (PFC), and amygdala express all three types, but the hippocampus expresses only 
MOR and DOR (Le Merrer et al., 2009). The most commonly clinically used opioids are 
potent MOR agonists (“Opioid drugs,” 2004). 1-8% of striatal neurons are positive for the 
mu opioid receptor (MOR), with the highest concentration in the NAc core, and the next 
highest in the NAc shell (Oude-Ophuis et al., 2014). MOR are usually perisynaptic. 
Postsynaptically, they regulate neuronal excitability and presynaptically they act to inhibit 
neurotransmitter release (Chartoff & Connery, 2014). 
 
Effects of Activation of Opioid Receptors 
 Opioid receptors exert a multitude of effects, including ionic homeostasis, 
regulation of cell proliferation, neuroprotection, modulation of immune systems, regulation 
of feeding, respiratory depression, regulation of the cardiovascular system, and of course, 
analgesia and addiction (Feng, et al., 2012). MOR, DOR, and KOR tonically inhibit 
nociception. MOR has the broadest effects on pain as it modulates mechanical, chemical, 
and thermal nociception controlled by the brain, mainly in the periaqueductal gray (PAG). 
DOR modulates inflammatory hyperalgesia, and KOR modulates spinally mediated 
thermal pain and visceral pain (Kieffer & Evans, 2009). Anti-pain effects occur by actions 
of opioids directly in the spinal cord to inhibit ascending pain sensation pathways, and also 
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in the brain to disinhibit the PAG and enhance descending pathways that inhibit spinal cord 
pain transmission (Feng, et al., 2012).  
MOR is the major opioid receptor involved in natural and drug reward, DOR may 
also mediate reward, but KOR activation is aversive (Le Merrer et al., 2009). Rewarding 
properties of MOR and DOR have been demonstrated in the hippocampus, periaqueductal 
gray, VTA, amygdala, and NAc (Le Merrer et al., 2009).  Opioid reward and analgesia 
exhibit tolerance effects, so that increased doses are necessary to achieve the same effect. 
There are multiple mechanisms by which tolerance may develop after acute and chronic 
opioid use. After acute agonist administration, opioid receptors undergo desensitization 
and internalization, while after chronic agonist administration, they develop adaptive 
tolerance and down-regulation (Feng, et al., 2012). Unfortunately, respiratory depression 
effects do not exhibit tolerance as readily as the other effects, making it easier to overdose 
on opioids. Respiratory depression is controlled by MORs that inhibit respiratory control 
centers in the brain stem (Feng, et al., 2012).  Tolerance may also occur due to 
compensatory responses in second messengers and in neural circuit activity that oppose 
opioid effects (Rohde, Detweiler, & Basbaum, 1996). Reward tolerance may be mediated 
by the VTA through chronic-morphine-induced brain derived neurotrophic factor signaling 
downregulation and decreased VTA neuron soma size (Russo, et al., 2007).  
Opioid receptors mediate withdrawal effects that occur after the cessation of 
chronic exogenous opioid administration. Withdrawal occurs because the compensatory 
mechanisms and opioid receptor changes that happen during the development of tolerance 
are unmasked by the drastic reduction in opioid tone, and therefore withdrawal symptoms 
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manifest as essentially the opposite of opioid agonist effects. Withdrawal can include 
autonomic symptoms such as nausea, diarrhea, sweating, shivering, and piloerection, 
central nervous symptoms such as insomnia, restlessness, and tremors, and pain symptoms 
(Preda, 2014). The complete pathophysiology of withdrawal is unknown, but the PAG 
clearly mediates withdrawal symptoms, with evidence for mediation by the locus coeruleus 
(LC), NAc, and spinal cord as well (Le Merrer et al., 2009; Rohde et al., 1996). 
 
Development of Opioid Addiction 
 The most commonly clinically used opioids are MOR agonists because of 
this receptor’s powerful ability to induce analgesia (“Opioid drugs,” 2004). Unfortunately, 
the MOR also mediates the most dangerous side effects of opioids used to treat pain: 
respiratory depression and a combination of reward, dependence, and tolerance that can 
lead to addiction. Addiction is theorized to develop in three stages. In the first stage, a 
person will take opioids for their rewarding effects. During this period there are short term 
brain adaptations that lead to withdrawal upon cessation of use. In the second stage, a 
person will continue to self-administer opioids to avoid withdrawal symptoms. Finally, in 
the third stage, the long-term use of opioids leads to chronic adaptations in the brain which 
underlie craving and compulsive drug-seeking (Kosten & George, 2002). People that use 
opioids may develop tolerance and dependence without progression to the third stage, 
which means they do not become addicted. The characteristics that differentiate between 
people who do or do not transition from tolerance and dependence to full blown addiction 
(third stage) is a subject of active research.  
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Clinical Diagnosis of Opioid Use Disorder 
 The Diagnostic and Statistical Manual of Mental Disorders, 5th Edition, 
does not use the word addiction. Rather, it uses the term “opioid use disorder,” defined as 
“a problematic pattern of opioid use leading to clinically significant impairment or 
distress.” The criteria for diagnosis include impaired control of substance use, social 
impairment, risky use, and/or pharmacological tolerance and withdrawal. One criterion of 
impaired control is drug craving, “an intense desire …for the drug.” Craving can quickly 
lead to opioid use, and must be overcome in order to prevent relapse in an individual who 
is trying to maintain abstinence (Havermans & Jansen, 2003). Craving is described as a 
phenomenon that can occur without provocation, but that “is more likely to occur when in 
an environment where the drug previously was obtained or used,” and is specifically 
associated with classical conditioning and activation of brain reward centers (American 
Psychiatric Association, 2013). Repeated drug use causes associations to form between 
drugs of abuse and accompanying cues and contexts. When an individual with an opioid 
use disorder encounters these cues or contexts they often experience drug craving, making 
them vulnerable to relapse and compulsive drug use (Franken et al. 1999). If these 
associations were better understood, new methods to diminish them could be more easily 
developed so that drug cues and contexts do not make individuals so vulnerable to relapse. 
Treatment of Opioid Use Disorder 
 The most effective medical treatment for opioid use disorder is opioid 
substitution therapy. When treating opioid use disorder, the goals are to help patients 
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reduce harm to themselves and others, to achieve abstinence, and to prevent relapse by 
establishing control over opioid use. Current pharmacological treatment involves the 
replacement of an abused opioid like heroin with another µ-opioid receptor agonist like 
methadone or a partial agonist like buprenorphine (“Painkillers fuel,” 2011). This therapy 
aims to reduce harm by preventing unregulated use of an abused opioid, thus helping to 
reduce the probability of overdose and the criminal or risky behaviors that go along with 
obtaining and administering opioids illicitly.  Opioid replacement can also help prevent 
relapse by diminishing withdrawal symptoms while partially satisfying craving.  
Nonetheless, many patients still experience craving while on a maintenance opioid, which 
may lead to relapse (See, 2002). Though opioid substitution is an effective treatment for 
opioid addiction, the replacement drugs are highly regulated and therefore patients’ access 
can be restricted. The replacement drugs also have problems related to lifetime use, 
diversion, abuse liability, and physical dependence. 
In addition to opioid substitution therapy, treatment may include behavioral and 
cognitive methods to modify psychological processes associated with compulsive drug use, 
including craving. Craving may be evoked when an addicted patient is exposed to 
"triggers," which are environments or objects that they previously learned to associate with 
an abused drug through classical conditioning (Mayet et al. 2005). It is almost impossible 
for a patient to avoid all triggers, so exposure therapy was developed to diminish triggered 
craving. In therapy, a trigger is repeatedly displayed to an abstinent patient to extinguish 
the association between drug and trigger (Mayet et al. 2005). Exposure therapy has been 
shown to diminish conditioned drug responses temporarily, but so far has not been shown 
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to prevent relapse in clinical trials (Havermans and Jansen, 2003). This extinction of drug 
associations is thought to constitute new learning, not forgetting, because extinction can be 
followed by spontaneous recurrence of previously extinguished behavior in a process 
called reinstatement (Havermans and Jansen, 2003). It follows that when addicts relapse 
they are undergoing reinstatement and their triggers become reactivated. Exposure therapy 
could benefit from the addition of a drug or a modification of the procedure to increase the 
strength of extinction and diminish reinstatement. 
 
Biological Basis of Addiction – Introduction to the Mesocorticolimbic Reward 
Circuit and Dopamine 
 The mesocorticolimbic system (Figure 1) is the brain circuit that has been 
most highly associated with addiction in the literature.  An important brain region in this 
system is the ventral tegmental area (VTA), which sends dopaminergic neurotransmitter 
projections from the midbrain to the nucleus accumbens (NAc). NAc neurons with 
dopamine-type-2 receptors (D2R) and dopamine-type-1-receptors (D1R) send GABAergic 
(inhibitory) projections to the ventral palladium (VP), while neurons with D1R, but without 
D2R, send GABAergic projections back to the VTA.  The VTA also sends projections to 
prefrontal cortex (PFC), amygdala, and hippocampus, and these regions send glutamatergic 
projections to the NAc (Richard & Berridge, 2011). 
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Figure 1: Mesocorticolimbic Reward System (Richard & Berridge, 2011). The 
major brain regions of the reward pathway are pictured. Glutamatergic signals are pictured 
in green, GABAergic are pictured in red, and dopaminergic are pictured in black. The 
ventral tegmental area sends dopamine to the nucleus accumbens, as well as to the cortex, 
hippocampus, and amygdala. The hippocampus, thalamus, amygdala, and the prefrontal 
cortex (made up of orbitofrontal, prelimbic, and infralimbic and other subregions) send 
glutamatergic projections to the accumbens. The accumbens neurons that express only D1 
dopamine receptors send GABA back to the ventral tegmental area, while the accumbens 
neurons that express D2 dopamine receptors send GABA to the ventral pallidum. The inset 
shows detail of the synapses in the nucleus accumbens. D1 dopamine receptors are only 
postsynaptic, while D2 receptors are pre and post synaptic. The glutamate receptor types 
are α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPA) and N-
methyl-D-aspartic acid (NMDA) receptors, and are postsynaptic.  
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 Dopamine Receptor Signaling 
  Dopamine receptors play a critical role in drug reward and the 
mesocorticolimbic system; they are seven-transmembrane receptors that are coupled to G-
proteins for intracellular signaling. There are two families of receptors, the dopamine 
receptor 1 (D1R) class, which are connected to the stimulatory Gs protein, and the 
dopamine receptor 2 (D2R) class, which are connected to the inhibitory Gi/o protein 
(Beaulieu & Gainetdinov, 2011).  The D1R class includes the D1 and D5 dopamine 
receptors, and the D2R class includes the D2, D3, and D4 dopamine receptors. This section 
focuses on the D1 and D2 receptors since they are the most highly expressed in the 
mesocorticolimbic system (Beaulieu & Gainetdinov, 2011). When the dopamine D1R is 
activated by dopamine, it undergoes a conformational change, and the GDP on the 
heterotrimeric Gs protein attached to the D1R is exchanged for a GTP. The exchange 
activates the Gs protein, so that the alpha and beta-gamma subunits dissociate from each 
other and from the D1R. The alpha subunit initiates a signaling cascade by activation of 
adenylate cyclase, raising cAMP levels, which activates PKA. PKA phosphorylates CREB, 
leading to a temporary increase in transcription and translation of the immediate early gene 
c-Fos (McClung & Nestler, 2008). Classically, the D2R related Gi protein inhibits 
production of cAMP, and therefore opposes the actions of Gs, but the Gβγ subunits can 
activate certain subtypes of adenylate cyclase (Yao, et al., 2002). The Gβγ subunits that are 
activated in response to D2R can also activate the phospholipase C signaling pathway, 
activate potassium channels, and inhibit L-type calcium channels (Beaulieu & 
Gainetdinov, 2011). Chronic drug use and addiction is correlated with increased levels of 
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transcription factor ΔFosB, which is slower to build, but lasts longer than increased cFos 
levels (Nestler, 2001). ΔFosB can be induced by long-term sitmulation of D1Rs and can 
alter synthesis of glutamate receptor subunits, and has been shown to specifically induce 
expresion of the alpha-amino-3-hydroxy-5-methyl-4-isoxazole (AMPA) glutamate 
receptor subunit type-2 (GluR2) subunits (Kelz, et al., 1999; Beaulieu & Gainetdinov, 
2011). Glutamatergic activity at the NAc core medium spiny neuron synapses can alter 
neuron morphology  (Kalivas & Volkow, 2005). 
 
 Dopamine Receptor Distribution in Brain and Neuron 
  The dopamine and mu opioid receptors have been shown to be 
expressed in almost all brain regions, including the mesocorticolimbic system, in regions 
such as the PFC, striatum, VTA, and amygdala (Sasaki, et al., 2014). The D1Rs and D2Rs 
are highly expressed, but the D3Rs, D4Rs, and D5Rs have lower levels of expression in 
general, so this section focuses on types 1 and 2 (Beaulieu & Gainetdinov, 2011). The D1R 
class of receptors is postsynaptic, while the D2R class can be presynaptic and postsynaptic 
(Beaulieu & Gainetdinov, 2011). D1R can be found throughout the neuron, including the 
axon and cell body, but it is mostly located on dendritic shafts and spines; specifically, 
about 35% of NAc spines express D1R (Muly, Maddox, & Khan, 2010).   
A more detailed explanation of receptor expression in the striatum is warranted, 
since dopamine in this region is hypothesized to mediate reward. About 30% of the cells, 
in the dorsal and ventral striatum equally, are positive for D1R, while about 20% express 
D2R. The proportion of neurons expressing both D1R and D2R in the striatum is very low. 
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About 15% of D1R neurons in the NAc core and shell coexpress D1R and MOR, which is 
significantly more than the 5-10% of dorsal striatum cells coexpressing these receptors. 
Around 10% of NAc core D2R cells coexpress MOR, while under 5% of all other D2R 
striatal region cells coexpress MOR. The NAc core is the region of the striatum with the 
highest coexpression of dopamine and mu opioid receptors (Oude-Ophuis et al., 2014). 
Acute morphine preferentially activates D1R-expressing over D2R-expressing neurons in 
the NAc (Enoksson, Bertran-Gonzalez, & Christie, 2012).  
 
Neurobiology of Opioid Reward and the Phases of Addiction 
 Opioid addiction is a biological learning process that involves pathology of 
brain and behavior. As mentioned, opioids are ligands for G protein-coupled opioid 
receptors of multiple subtypes (δ, κ, and μ) which are widely distributed throughout the 
brain, including the mesocorticolimbic circuit. Morphine is hypothesized to create reward 
by binding to mu opioid receptors on VTA inhibitory interneurons, thereby inhibiting them. 
When interneurons are inhibited there is disinhibition of the projection neurons of the VTA, 
causing the VTA to increase dopamine release into the NAc (Johnson & North, 1992). 
Additionally, reward may be produced by direct opioid binding to MORs in the NAc (Van 
der Kooy et al., 1982). In drug-naïve humans, a single morphine administration activates 
the NAc as measured by functional magnetic resonance imaging (Becerra et al. 2006). The 
NAc is subdivided into core and shell regions that are functionally distinct and differ in 
their connectivity to other brain regions (Millan, Marchant & McNally 2011). The NAc 
shell receives mainly limbic input, and is hypothesized to be involved in emotional and 
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motivational responses while the NAc core receives sensorimotor input, and has been 
linked to classical conditioning that associates drugs of abuse with context (Sesack and 
Grace, 2010; Everitt and Robbins, 2005).  
Repeated use of opioids transitions to addiction when neuroadaptive changes occur 
in the mesocorticolimbic dopamine system and produce behavioral changes in the 
individual. These behavioral changes include drug craving in the absence of drug and 
uncontrolled drug intake. The transition from taking opioids for reward effects to taking 
them to avoid withdrawal is produced by opioid-induced brain adaptations. Since opioids 
induce dopamine release from the VTA, it is thought that, in an opponent process, tonic 
dopamine release is downregulated. After chronic drug use, drug discontinuation is 
associated with even lower dopamine levels than in a drug-naïve individual, producing 
dysphoria (Koob, 2006). Similarly, the LC is inhibited by opioids, and so LC activity is 
upregulated with chronic use, and is overactive in the drug-free state, leading to aversive 
withdrawal symptoms (Kosten & George, 2002).  
The transition from drug use for avoidance of withdrawal to compulsive drug use 
occurs in more advanced addiction and is due, in part, to learning-related brain adaptations. 
Di Chiara theorizes that repeated dopamine release into the NAc occurring with drug use 
creates stronger reward-cue associations than the dopamine release occurring with natural 
reward. This is because dopamine release due to natural reward habituates within a trial, 
while dopamine release due to drugs remains elevated. The drug-associated stimuli gain 
more incentive salience than natural reward-associated stimuli, thus leading drug cues to 
obtain utmost importance over all other cues, resulting in craving and compulsive drug use 
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(Di Chiara, 1999). Additionally, abstinence may be hard to maintain after cessation of 
chronic opioid use because natural reward is blunted by downregulation of dopamine 
release and receptors (Volkow, et al., 2010). Therefore, even in the abstinent state, non-
drug stimuli may continue to have little salience, and therefore little influence on behavior, 
making drug-related behavior dominant.  
 
Brain Circuitry of Drug Cues and Drug Seeking  
 Neural connectivity is contributory to addiction, as patients have pathology 
in the structure and function of the mesocorticolimbic system.  Patients with opioid use 
disorders have altered functional connectivity between the NAc and other brain regions 
(Upadhyay, et al., 2010). They also have impairments in PFC-mediated executive function. 
For example, single-photon emission tomography imaging of heroin abusers in a neutral 
state has identified hypoperfusion of the PFC (Botelho, et al., 2006).  
The disrupted function and connectivity of brain regions seen in patients with 
opioid use disorder reflects adaptations related to opponent processes, withdrawal effects, 
and, specifically relevant to the studies within this work, excessive motivation for drugs 
and related cues. Dopamine released into the NAc by drugs of abuse signals reward and 
triggers learned associations between the motivational signal and co-occurring 
environmental stimuli, as would occur in morphine CPP acquisition (Kalivas & Volkow, 
2005).  After the pairing of drug administration with external stimuli, dopamine release 
will occur not only in response to a drug exposure, but to a drug-associated cue by itself 
(Kalivas & Volkow, 2005).  
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In contrast to the brain’s neutral state in persons with opioid abuse disorder, in 
which the PFC in underactive, exposure to drug-related cues results in neural hyperactivity 
of the PFC, VTA, and amygdalas (Zijlstra et al., 2009). This hyperactivity is correlated 
with self-reported drug craving. A drug related cue causes the VTA neurons to fire, 
increasing dopamine output to the PFC, NAc, and basolateral amygdala (BLA), activating 
these regions (Diana, 2011). The PFC is activated through excitatory connections from the 
BLA, and also by the direct influence of dopamine on the PFC (Kalivas & Volkow, 2005). 
Activation of the PFC sends glutamatergic input to the NAc core, which in turn sends 
endogenous opioid input to the VP, which projects to the motor systems. The NAc core to 
VP connection directly mediates the expression of cue-activated behavior that culminates 
in drug seeking, as well as motivated drug-related behavior as occurs in expression of CPP 
(Root D., et al., 2012).  
The medial PFC (mPFC) is subdivided into prelimbic (PL) and infralimbic (IL) 
subregions. It is thought that the PL activates the NAc core, which then sends endogenous 
opioids to the VP. Opioids inhibit VP interneurons, thereby disinhibiting the VP projection 
neurons that promote drug seeking motor behavior (Pizzimenti & Lattal, 2015) The IL may 
be responsible for inhibition of drug seeking behavior through its excitatory projection to 
the NAc shell, which inhibits the medial VP through GABAergic projections (Pizzimenti 
& Lattal, 2015).  
 
 
 
16 
 
Conditioned Place Preference is a Model of Trigger Formation in Drug Addiction 
 Conditioned place preference (CPP) is used to model trigger formation and 
extinction—in other words, how learned associations form between motivational events 
and neutral stimuli in addiction (Kalivas & Volkow, 2005; Zhang, Ma, & Yu, 2012). In the 
CPP paradigm, animals are trained to develop a preference for a context they associate with 
a drug. Morphine is the prototypical µ-agonist opioid used in animal models to study opioid 
addiction, and is used clinically. To acquire morphine CPP, an animal is confined to a 
chamber after being injected with morphine. On alternate days, it is confined to a separate 
chamber after being injected with saline. After multiple trainings, animals undergo 
preference testing with free access to both chambers, and express CPP if they spend a 
majority of the time in the chamber associated with morphine (Heinrichs et al., 2010). CPP 
can detect the strength of drug reward, as time spent in the drug associated chamber is 
dose-dependent (Leite-Morris et al. 2014). CPP is extinguished by repeatedly confining 
drug-free animals to the chamber previously associated with morphine and, on alternate 
days, to the saline chamber. Extinction occurs when the animals no longer choose to spend 
more time in the morphine chamber during a preference test (Heinrichs et al., 2010). 
Extinction is thought to be new learning, not simply forgetting CPP, because CPP behavior 
can recover. Reinstatement is thought to reflect reactivation of a CPP neural trace that was 
suppressed by an inhibitory pathway created by extinction (Bouton, 2004). CPP can be 
reinstated by priming an extinguished animal with a morphine injection. When preference 
tested after morphine priming, animals will again show CPP and spend a majority of time 
in the morphine-associated chamber (Shaham et al., 2003).  
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CPP not only models human behavior but is directly relevant to our species since it 
has been demonstrated in humans using d-amphetamine (Childs & de Wit, 2013). Murine 
CPP extinction training models the basis of exposure therapy used in treatment of 
addiction. In exposure therapy, individuals are exposed to drug cues and contexts and learn 
not to respond to them. Therefore, examining CPP extinction, and ways to strengthen it, is 
particularly critical for improving exposure therapy. CPP is uniquely useful in studying 
drug-associated learning and behavior in drug-free animals, allowing researchers to 
differentiate between acute drug effects and learning process effects. Reinstatement of CPP 
reflects human relapse. Understanding how to diminish it could help addicted patients. 
 
 Role of Nucleus Accumbens in CPP 
 As described above, the NAc has a critical role in drug-related association 
formation and extinction, and therefore also in CPP, which models these processes. 
Conditioned place preference involves highly specific and reward-based learning. As such, 
it involves plasticity in the mesocorticolimbic reward circuit. As a part of this circuit, the 
NAc is a crucial mediator of opioid CPP (Lintas, et al., 2011; German & Fields, 2007; 
Comeau et al., 2010; Kalivas & O'Brien, 2008). The NAc has been cited as the central 
location for the signaling of drug reward, and a region that combines motivational states 
and related motor behavior (Theberge et al., 2010). Morphine CPP occurs not only with 
systemic morphine and intra-VTA morphine but also with morphine injected exclusively 
into the NAc (Van der Kooy et al., 1982). More recently, it has been proposed that, at least 
in the context of natural reward, there are multiple individual loops that convey information 
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about predictive cues, motivation, and hedonic value from the NAc to the VP, and that 
these regions actually control reward motivation, as opposed to simply passing on 
information about it (Smith, Berridge, & Aldridge, 2011). 
Neuronal activity of both core and shell NAc subregions is necessary for the 
acquisition of opioid CPP (Esmaeili, et al., 2012). After CPP acquisition, long-term 
electrophysiological changes occur in subsets of NAc neurons which fire differentially with 
exposure to saline versus morphine associated contexts (German & Fields, 2007). There 
have been no lesion or inactivation studies of the role of the NAc in CPP extinction, but it 
was shown that inhibition of phosphodiesterase 10A, a striatally expressed form, 
accelerated morphine CPP extinction (Mu, et al., 2014). The role of the NAc in CPP 
extinction has also been studied using cocaine as the drug of abuse. Inhibition of 
proteasome degradation in the NAc core blocked cocaine CPP extinction (no effect in the 
shell), while extinction was enhanced by intra-NAc core and shell inhibition of protein 
kinase M zeta (Ren, et al., 2013; Shabashov et al., 2012). Such mechanisms have not been 
studied in opioid CPP and its extinction.       
 
Dopamine’s Role in CPP 
 Dopamine has a clear role in opioid reward. Both dopamine receptor agonist 
and antagonist drugs for different receptor subtypes appear to affect acquisition and 
extinction of conditioned drug reward in animal studies. Intraperitoneal injection and intra-
NAc shell injection of SCH39166 (D1R antagonist) or sulpiride (D2R antagonist) before 
morphine injection blocked animals from acquiring morphine CPP (Acquas et al., 1989; 
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Fenu et al., 2006). Pretreatment with the D2R and serotonin 5HT1A partial agonist/5HT2A 
antagonist aripiprazole decreased morphine priming induced CPP reinstatement in rats (Li 
et al., 2009). Most of the work with dopamine receptor agents in CPP extinction has been 
performed with stimulant drugs. Systemic administration of the D1R antagonist SCH39166 
(ecopipam) impaired extinction of cocaine CPP in animals, while acute, but not chronic, 
ecopipam was able to reduce the reinforcing effects of cocaine in humans (Fricks-Gleason 
et al, 2012; Pierce et al., 2012). It is clear that D1R agents interfere with morphine reward 
and that D1R antagonists can prevent morphine CPP acquisition. The field particularly 
lacks information on the role of dopamine receptors in morphine CPP extinction. 
Determining how D1R agents modulate CPP behavior will increase our knowledge of the 
neurobiological function of dopamine receptors in conditioned drug reward and its 
extinction. Such information could improve interventions for cue- and context-induced 
opioid relapse. 
 
Drug-Related Structural Plasticity in the Nucleus Accumbens 
 In addition to electrophysiological plasticity, NAc neurons demonstrate 
structural plasticity in response to drugs of abuse and associated learning. Structural 
plasticity refers to the ability of neurons to change their dendritic and spine morphology. 
Dendritic morphology is an important measure of plasticity because dendrites and spines 
are the points of synaptic connection between neurons. Structure is linked to function, so 
neuron morphology is an important aspect of neuron connectivity (Dillon & Goda, 2005). 
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Changes in neuron morphology have functional implications because they reflect changes 
in electrotonic properties of neurons and synaptic strength (Schubert & Dotti, 2007).  
Drugs of abuse and learning associated with these drugs alter neuron morphology 
in mesocorticolimbic brain regions. Stimulant drugs of abuse have been shown to increase 
spine density and dendritic complexity in the NAc shell and core, while ethanol has been 
shown to reduce spine density (Robinson & Kolb 2004; Zhou et al. 2007).  Studies using 
stimulants show that rats conditioned with amphetamine have more asymmetric, excitatory 
synapses in the basolateral amygdala than controls (Rademacher et al., 2010; Marie et al., 
2012). Cocaine place preference score positively correlates with increased spine density in 
the NAc core and shell, and with new persistent spine formation in the frontal cortex 
viewed by in vivo imaging (Marie et al. 2012; Munoz-Cuevas et al., 2013).  
Opioids have their own specific effects on neuron morphology. Neurons in the 
prelimbic cortex of rats that learn to self-administer morphine have longer dendrites and 
higher spine density than those of rats self-administering saline, while motor cortical 
neurons have shortened dendrites with fewer branches (Ballesteros-Yanez et al., 2007). 
NAc shell neurons of rats that are passively injected with morphine, then withdrawn for 
approximately a month, have decreased spine density and dendritic complexity (Robinson 
& Kolb, 1999), while rats that learn to self-administer the same doses of morphine show 
even more dramatic decreases in NAc shell neuronal structural complexity (Robinson et 
al, 2002). Such differences between routes of morphine administration paradigms suggest 
that changes in structural plasticity are probably due to both drug administration and 
learning interactions (Russo et al., 2010). It is known that morphine alters the morphology 
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of neurons in the NAc, but the effect of CPP on morphology in the NAc has only been 
studied with stimulants. There is no data, to my knowledge, on structural plasticity 
associated with opioid CPP and its extinction. 
 
Significance of Structural Plasticity 
 Dendritic morphology is one characteristic of a neuron that is responsible 
for its electrotonic properties, that is, how electric current will spread from the original 
point of voltage change through the rest of the of the dendrite without the generation of 
new current as in action potentials (Luebke, Barbas, & Peters, 2010). Rall was the main 
investigator to develop the theory of how structure would affect current propagation in the 
neuron by modeling neuronal processes as cables and using circuit theory to describe their 
properties with simplified compartment models (Shepherd, 2008). If the radius of a process 
is increased, the resistance to current flow down its length will decrease faster than resting 
membrane resistance, so that thick dendrites will transmit voltage changes a longer distance 
down the length of the process than thinner dendrites. It happens that dendrites are often 
short enough so that current does not decay much as a function of the length it has to travel, 
so other properties have an even greater influence on current propagation (Shepherd, 2008). 
Dendrites act as low-pass filters, meaning that they convert high amplitude, rapid post-
synaptic potentials into lower amplitude, delayed, longer-lasting potentials by the time the 
signal reaches the soma. Dendrites do this because current does not move in a single direct 
path. Rather, the membrane acts as a capacitor, so that after many ion channels open, the 
membrane becomes charged and current moves towards the membrane as well as down the 
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length of the dendrite, so that the dendritic membrane slows and partially dissipates the 
current’s flow toward the soma (Segev, 2006; Shepherd, 2008). Increasing the radius of a 
process will increase its capacitance by adding more membrane. Adding membrane in the 
form of more dendrites or dendritic spines will also increase capacitance. Increased 
capacitance causes more low-pass filtering. Multiple active synapses that are multiple 
points of current generation must be integrated for the signals to boost one another and lead 
to significant effects on the soma (Carter, Soler-Llavina, & Sabatini, 2007).   
Not only do dendrites control the transmission of post-synaptic signals to the soma, 
but they also mediate effects of back-propagation of action potentials. Besides moving 
towards the pre-synaptic axonal boutoun, an action potential in the axon can move 
“backwards” through the soma and into the dendrites. This will depolarize the dendritic 
membrane, opening its voltage gated channels, which will then be able to pass current 
down its length again, and back to the soma, producing afterdepolarization that may 
reactivate action potentials (Bean, 2007). Large dendritic arbors are necessary for a neuron 
to exhibit afterdepolarizations, which are necessary for a neuron to produce burst firing 
activity in the axon (Mainen & Sejnowski, 1996). Burst firing is important because the 
integration of dendritic signals is encoded by the frequency of action potentials generated 
in the axon (Gerstner et al., 1997). There is also evidence that potentials from dendrites 
may spread a significant distance along the axon. In this case, encoding may be achieved 
by dendritic potential duration and amplitude, which ultimately would change the 
amplitude of post-synaptic potentials generated by the axon (Shu et al., 2006). This means 
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that dendritic potentials that do not summate enough to produce an action potential may 
encode information and affect neurotransmission.  
Dendrites branch so that the segment attached to the soma splits into two segments, 
those two segments split into four segments, and so on. If there are more branch points in 
a neuron, there will be more compartmentalization of signaling in each dendrite because 
dendritic branches are points where a signal will attenuate (Branco & Hausser, 2010). Since 
the dendrites on either side of the branch usually have different radii, they will have 
different resistances. Usually, the more proximal dendrite will have a larger size, and will 
therefore have lower input membrane resistance, and so will have a smaller voltage change 
for a given current. So, at branch points, in the proximal larger dendrites, there is a smaller 
change in voltage, or a smaller change in membrane potential, than in the smaller dendrite 
distal to the branch point, leading to signal attenuation (Ferrante, Migliore, & Ascoli, 
2013). On the other hand, having more branches also means a greater separation of 
synapses. This is important because synapses that simultaneously fire on the same dendrite 
will result in sublinear summation of the signal (Spruston, 2009). Depolarization of the 
membrane reduces the driving force for depolarizing ions to move into the dendrite; 
essentially, the ions don’t feel the drive to flow into the dendrite at point 2 as much as usual 
since they’re already doing so and reaching toward their equilibrium at point 1. When 
synapses are on different dendrites, the summation of signals is more linear because a 
change in the driving force across the membrane of one will not affect the other (Spruston, 
2009). This means that synapses activated at the same time on different dendrites have the 
potential to produce a stronger signal than synapses activated on the same dendrite.  
24 
 
At the synaptic level, long term depression (LTD) is correlated with shrinkage and 
retraction of spines, while long term potentiation (LTP) is correlated with stabilization of 
mushroom shaped spines with increased concentrations of AMPA receptors at enlarged 
post-synaptic densities (Russo et al., 2010). Dopamine, an essential part of morphine’s 
mechanism, has been shown to modulate LTP, LTD, and induce changes in neuron 
structure by increasing dendritic spine density (Yao, Spealman, & Zhang, 2008; Fasano, et 
al., 2013). 
 
Dopamine’s Role in Accumbens Structural Plasticity 
 Dopamine plays an essential role in drug reward and neuron morphology as 
a neurotransmitter in the mesolimbic reward pathway. After dopamine depletion, MSNs in 
dendrites of the NAc core and lateral shell are shortened and have fewer spines and 
decreased spine density. In the medial shell, dendrites have decreased spine density and 
more tortuous dendrites, and a higher number of spines (Meredith, Ypma, & Zahm, 1995). 
Administration of D1R or D2R agonists to medium spiny neurons (MSNs) in vitro causes 
increased dendritic spine density, while co-culture of MSNs with dopaminergic neurons 
causes increased dendritic arborization in MSNs (Fasano et al., 2013). Repeated activation 
of D1R with the D1R agonist SKF81297 caused increased dendritic complexity and spine 
density of cortical neurons in vitro (Li, et al., 2014). D1R activation also increased levels 
of the active guanosine triphosphate (GTP) bound form of the GTPase Rac1, and decreased 
levels of the active, GTP-bound form of the RhoA GTPase (Li, et al., 2014).  Rac1 
deactivates cofilin, which normally severs F-actin, therefore destabilizing the dendritic 
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cytoskeleton. If Rac1 is increased, levels of active cofilin will decrease, which may 
stabilize outgrowths of the dendrite, highlighting a possible mechanism for how D1R may 
increase morphological complexity through structural proteins. 
  
 Summary 
  Changes in neuronal structure and reward signaling pathways in the NAc 
have been found to occur after experimenter-administered opioid administration, and after 
conditioned self-administration of morphine. It is important to investigate changes in 
accumbal neuronal structure and signaling pathways that occur after morphine conditioned 
reward and its extinction because of its relevance to opioid addiction in humans. The 
morphine conditioned place preference (CPP) paradigm, and its extinction, model the drug 
conditioning that can occur in humans. The goal of the following research is to understand 
how opioid conditioning alters accumbal structural plasticity. The central hypothesis of 
this work is that morphine CPP acquisition and extinction have opposing effects on the 
structural complexity of neurons in the nucleus accumbens. This research seeks to 
understand acquisition and extinction of associations between drug and environment. As 
such, it can contribute to the understanding of how drug-related learning occurs and 
possibly provide targets for development of treatments that prevent relapse.   
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Chapter 2: Acquisition of morphine conditioned place preference increases the 
dendritic complexity of nucleus accumbens core neurons 
 
Data presented in this chapter are in press: 
 
Kobrin KL, Moody O, Arena DT, Moore CF, Heinrichs SC, Kaplan GB 
Addiction Biology (2015). 
 
Abstract 
 Contexts associated with opioid reward trigger craving and relapse in opioid 
addiction. Effects of reward-context associative learning on nucleus accumbens (NAc) 
dendritic morphology were studied using morphine conditioned place preference (CPP). 
Morphine-conditioned mice received saline and morphine 10 mg/kg subcutaneous (s.c.) 
on alternate days. Saline-conditioned mice received saline s.c. each day. Morphine-
conditioned and saline-conditioned groups received injections immediately before each 
of eight daily conditioning sessions. Morphine homecage controls had no CPP training, 
but received saline and morphine in the homecage concomitantly with the morphine-
conditioned group. Morphine conditioning produced greater place preference than saline 
conditioning. Mice were sacrificed 1 day after CPP expression. Dendritic changes were 
studied using Golgi-Cox staining and digital tracing of NAc core and shell neurons. In 
the NAc core, morphine homecage administration increased spine density, while 
morphine conditioning increased dendritic complexity, as defined by increased dendritic 
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count, length and intersections. Place preference positively correlated with dendritic 
length and intersections in the NAc core. The core may mediate reward consolidation and 
determine how context-related signals from the shell lead to motor behavior. The 
combination of drug and conditioning in the morphine-conditioned group produced 
unique morphological effects different from the effects of drug or conditioning 
procedures by themselves. An additional study found no differences in neuron 
morphology between saline-conditioned mice, trained as described earlier, and mice that 
were not conditioned, but received saline in the homecage. The unique effect of morphine 
reward learning on NAc core dendrites reflects a brain substrate that could be targeted for 
therapeutic intervention in addiction. 
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2.1 Introduction 
 Opioid addiction is a growing problem in the United States and is associated with 
diversion and misuse of opioid pain relievers. Often, misuse of prescribed opioids leads to 
addiction to less costly heroin. Opioid addiction produces tremendous morbidity and 
mortality and can be associated with health problems and criminal justice system 
involvement (Hser et al. 2001). In addition to opioid replacement therapy, treatment may 
include behavioral and cognitive methods to modify behaviors associated with compulsive 
drug use. The goals of opioid use disorder (OUD) treatment include helping patients reduce 
harm, achieve abstinence, and prevent relapse.  
 Cues and contexts that coincide with repeated drug use become associated with the 
drug (Tzschentke 2007). When an individual with OUD encounters these cues or contexts 
they often experience drug craving, making them vulnerable to compulsive drug use and 
relapse (Franken et al. 1999). Further characterization of brain substrates underlying these 
associations provides targets for treatment development. 
 The conditioned place preference (CPP) animal model has been used extensively 
in addiction research to study context-mediated drug reward and its extinction (Tzschentke 
2007). In the model, drug administration is paired with one context, while saline 
administration is paired with another context. CPP can detect the presence and strength of 
drug reward because an animal spends more time in the chamber associated with a drug of 
abuse than in the chamber associated with saline, and time spent in the drug associated 
chamber is dose-dependent (Leite-Morris et al. 2014). CPP is used frequently to study 
behavioral and biological changes associated with drug reward. Biomarkers involved in 
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addiction and drug-taking, such as transcription factor c-Fos, and opioid, dopamine, and 
glutamate neurotransmission, are altered in the nucleus accumbens (NAc) in morphine CPP 
(Leite-Morris et al. 2004; Moron et al. 2010; Weitemier & Murphy 2009).  
 The NAc is an essential part of the mesocorticolimbic dopamine pathway that 
mediates opioid reward and addiction. The NAc contains medium spiny neurons (MSNs) 
that receive dopaminergic and glutamatergic afferents onto their dendrites and spines, and 
send out GABAergic efferents (Pierce & Wolf 2013). Opioids may produce drug reward 
by acting directly in the NAc, and/or by disinhibiting dopaminergic neurons in the ventral 
tegmental area, causing them to release increased amounts of dopamine into the NAc 
(Luscher, 2012; van der Kooy et al. 1982). In drug-naïve humans, a single morphine 
administration activates the NAc as measured by functional magnetic resonance imaging 
(Becerra et al. 2006). The NAc appears to be involved in the pathophysiology of patients 
with OUD as these patients have altered functional connectivity between the NAc and other 
brain regions upon imaging (Upadhyay et al. 2010). Studies in rodents show that the NAc 
is necessary for, and altered by, morphine CPP. Interrupting NAc function by injection of 
protein synthesis inhibitor into the NAc after each morphine-environment pairing blocks 
CPP acquisition in a context-dependent manner (Milekic et al. 2006). After morphine CPP, 
groups of NAc neurons have persistent and distinct patterns of firing associated with the 
morphine versus the saline paired context (German & Fields 2007).   
 The NAc is subdivided into functionally distinct core and shell regions that differ 
in their connectivity to other brain regions (Millan, Marchant & McNally 2011). When 
performed after CPP acquisition, lesion and transitory inactivation of the core, but not the 
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shell, prevent CPP expression, while lesions of the core and shell attenuate CPP 
reinstatement (Wang et al. 2008; Liu et al. 2008; Wang et al. 2002). The NAc core may 
serve a more regulatory function than the shell during drug CPP because the core can 
control the effects of CPP on the shell and can integrate context related signals from the 
shell with its own output to motor regions (Marie, Canestrelli & Noble 2012; Ito & Hayen 
2011).  
 Accumbal neuron morphology is altered by administration of drugs of abuse and 
associated learning. Dendritic morphology is an important measure of plasticity because 
dendrites and spines are the points of synaptic connection between neurons. For example, 
increased spine size is associated with increased synaptic strength by long term potentiation 
(Matsuzaki et al. 2004). Stimulant drugs of abuse have been shown to increase spine 
density and dendritic complexity of neurons in the NAc shell and core, while ethanol has 
been shown to reduce spine density (Robinson & Kolb 2004; Zhou et al. 2007). Cocaine 
place preference score positively correlates with increased spine density in the NAc core 
and shell (Marie, Canestrelli & Noble 2012). Withdrawal from self- and experimenter-
administered morphine leads to reduced dendritic branching and spine density of murine 
NAc shell MSNs (Robinson & Kolb 1999; Robinson et al. 2002).  However, studies have 
not examined accumbal dendritic complexity after opioid CPP acquisition, and our 
research addresses this gap in knowledge. 
 We explored how morphine and morphine-related learning interact to alter MSN 
morphology in the NAc. We used an optimally effective morphine dose (10 mg/kg s.c.) to 
induce CPP in mice, or saline as a control, and then tested them for place preference (Leite-
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Morris et al. 2014).  As a control condition, we simultaneously injected another cohort of 
mice with morphine in their homecages. After CPP expression was confirmed, brain 
samples were processed using Golgi-Cox staining to identify single MSNs in the NAc core 
and shell. We analyzed morphology by comparing dendritic complexity and spine density 
measures between groups. We performed a separate study to control for exposure to the 
CPP apparatus by comparing dendritic morphology of saline-conditioned mice and mice 
that received saline in the homecage. 
 
2.2 Material and Methods 
 2.2.1 Animals 
 Male C57BL/6 mice from Charles River Laboratories (Raleigh, SC) were used 
because they display measurable indications of reward, stimulation, and sensitization in 
response to morphine (Leite-Morris et al. 2004; Heinrichs et al. 2010). Mice were housed 
in groups of 4 and acclimated to a 12 hour (7AM-7PM) light/dark cycle for at least 7 days 
before the study. Animal testing was performed between 7 AM-7PM in a facility approved 
by the Association for the Assessment and Accreditation of Laboratory Animal Care and 
approved by the Institutional Animal Care and Use Committee (IACUC) of the VA Boston 
Healthcare System. The experiments were carried out in accordance with the Guide for the 
Care and Use of Laboratory Animals as adopted and promulgated by the National Institutes 
of Health. For all studies, neuron morphology data were gathered from behavioral groups 
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that were saline-conditioned (n =5 or 8) or morphine-conditioned (n = 8) and from 
administration controls that were given saline (n = 5) or morphine (n = 7) in the homecage.  
 2.2.2 Drug Administration 
 A subcutaneous (s.c.) 10 mg/kg dose of morphine was administered to the 
morphine-conditioned and morphine homecage treatment groups. Morphine dose, 
administration route, and time of administration were selected based on past experience 
with CPP (Heinrichs et al. 2010; Leite-Morris et al. 2014). 
 2.2.3 Morphine Place Conditioning 
 For a visual summary of the procedures, see Figure 2. Mice were trained to acquire 
CPP in an apparatus (Mouse Place Preference; Med Associates, St. Albans, VT) consisting 
of a middle chamber (7.25 x 12.70 cm) with automatic guillotine doors situated in between 
two black conditioning chambers of equal size (16.75 x 12.70 cm), differentiated by left or 
right location relative to the middle chamber and by mesh or bar flooring type (Leite-
Morris et al. 2014). Interruption of infrared beams inside the chambers tracked movement 
of animals over time, and was used to calculate the total time a mouse spent in each 
chamber. 
 CPP training was preceded by a pre-conditioning preference test on day 0. Mice 
were acclimated in the middle chamber for 30 seconds. Then, doors opened automatically 
and mice were allowed 15 minutes of free access to all chambers. Total time spent in each 
of the conditioning chambers was recorded. Because our design is unbiased, mice that 
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exhibited an unconditioned place preference, or spent more than 67% of the total time in 
one chamber, were labelled biased and excluded from the study (n=2).  
 During conditioning, morphine (10 mg/kg) and saline were subcutaneously 
administered on alternating days to morphine CPP mice (n=8). Immediately after being 
injected with saline or morphine, mice were placed in the assigned conditioning chamber 
for 50 minutes (days 1-8). For balanced conditioning, half of the morphine-conditioned 
mice associated morphine with the left, and half with the right conditioning chamber. The 
chamber not assigned to morphine served as an internal control, and was associated with 
saline treatment. Saline-conditioned mice (n=8) received saline s.c. every day, and were 
placed in left or right conditioning chambers on alternating days (Heinrichs et al., 2010). 
The morphine homecage group (n=7) received morphine (10 mg/kg) or saline s.c. on 
alternating days, in their homecages, in the testing room, on the same schedule as the 
morphine-conditioned group.  
 Neurons of morphine-conditioned mice were exposed to the effects of morphine 
and to the effects of the CPP environment. A morphine homecage group was included to 
control for the effect of exposure to morphine on morphology. Likewise, a separate control 
study was performed to isolate the effect of exposure to the CPP environment on dendritic 
morphology changes. A saline-conditioned group (n=5) was run as described above. As a 
saline administration control, a saline homecage group (n=5) received saline injections on 
all days, in the testing room, on the same schedule as the saline CPP group.  
For both studies, one day after the final conditioning session (day 9), mice exposed to 
CPP training underwent a post-conditioning preference test identical to the pre-
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conditioning preference test performed on day 0. “Preference score” was defined as time 
spent in the morphine-paired chamber minus time spent in the saline-paired chamber. 
  
 
Figure 2: Experimental design for morphine conditioned place preference (CPP). On Day 
1 mice were tested for an unconditioned pre-conditioning place preference. During CPP 
development (days 2-9), mice were administered either morphine and confined to one 
conditioning chamber, the conditioned stimulus + (CS+), or saline and confined to the other 
conditioning chamber, the conditioned stimulus - (CS-). On Day 10 post-conditioning 
preference tests for expression of CPP were performed. On day 11 mice were euthanized 
and brains were harvested for Golgi-Cox staining. 
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 2.2.4 Dendritic Morphology Procedures 
 Mice for both studies were sacrificed by sodium pentobarbital injection on day 10, 
one day after the post-conditioning preference test. Brains were removed and stained using 
the FD Rapid GolgiStainTM Kit (FD NeuroTechnologies, Inc., Catonsville, MD). After 
Golgi stain immersion in solutions A & B, whole brains were snap-frozen in 2-
methylbutane, encased in Tissue Freezing Medium (Triangle Biomedical Sciences, In., 
Durham, NC, USA), sectioned at 100 µm on a cryostat microtome (Leica Microsystems 
Inc., Buffalo Grove, IL), and mounted on chrome alum gelatin coated slides. Sections then 
underwent the rest of the Golgi stain process using the directions from the GolgiStainTM 
Kit. Sections were dried for at least 3 days. After drying, sections were washed in water, 
then stained with solutions C & D, and washed in water again. Sections were then 
dehydrated in increasing concentrations of ethanol, followed by clearing in xylene. Slides 
were coverslipped and mounted with Permount (Thermo Fisher Scientific, Waltham, MA). 
 Sections containing the NAc were visualized with an Olympus BX51 bright field 
microscope interfaced with a color digital camera (MicroFire Optronics, Goleta, CA). 
Neurons were manually traced within the NAc between rostral/caudal coordinates +1.54 
to +0.98 mm relative to bregma. Neurons for NAc core tracings had cell bodies located 
within 150 µm from the edges of the anterior commissure. Neurons for NAc shell tracings 
had cell bodies located 500-1000 µm from the medial or ventrolateral edges of the anterior 
commissure (Franklin & Paxinos 2007). MSNs were defined as having distinct individual 
dendrites and dense groupings of at least four adjacent spines distributed along the length 
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of dendritic segments. Interneurons, with distinct individual dendrites, but without dense 
spines, and astrocytes, with numerous projections in a radial distribution, were not traced 
(Tepper et al. 2010). All dendrites on 3-5 individual MSNs per mouse were manually 
traced at 60X using Neurolucida software (MBF Bioscience, Williston, VT). NAc core and 
shell MSNs were traced for the morphine CPP study. NAc core MSNs were traced for the 
saline CPP versus saline homecage control study.  
Our approach was to trace dendritic spines in the NAc core on the most highly 
branched, longest dendritic tree of each neuron. We chose this tree as the most 
representative dendritic segment because it provides spine data for all branch orders in an 
MSN. Estimation of spine density using a sampling of dendritic segments has been 
performed by other research groups (Brown & Kolb 2001; Juarez et al. 2011). The software 
automatically analyzed each tracing for spine density, dendritic length, dendritic count, and 
Sholl analysis in order to evaluate spines and dendritic arborization. In the Sholl analysis, 
equidistant (10 µm) concentric circles are superimposed on the neuron tracing, and 
centered on the soma. The number of times each circle is crossed by a dendrite is tabulated 
as the number of intersections at each radius and is a measure of dendritic arbor complexity 
(Binley et al. 2014). We manually calculated spine density (number of spines per 10 μm 
of dendrite) by dividing the total number of spines by the total length of dendrite upon 
which spines were counted, and then multiplying this product by 10. 
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 2.2.5 Statistical Analysis  
 Data were analyzed using GraphPad Prism 6.0 (GraphPad, La Jolla, CA, USA).  
Significance for analyses was set at the p<0.05 level. Behavioral data from the morphine 
CPP study were examined using two-way repeated measures ANOVA, with factors of time 
(pre-test to post-conditioning preference test) and treatment group, followed by a post-hoc 
Sidak’s multiple comparisons test to compare treatment groups at each level of the 
experimental phase. Behavioral data from the saline CPP control study were examined 
using a paired t-test to compare preference scores of saline-conditioned mice before and 
after conditioning.  
 Data for each morphology measure from 3-5 neurons per mouse were averaged to 
create individual values for each mouse that were then averaged together to create mean 
values for each group. Dendritic parameters for the morphine CPP study, including total 
dendritic length, total dendritic count, and spine density, were examined using one-way 
ANOVA, followed by post-hoc Tukey’s multiple comparisons tests. For the CPP exposure 
control study, dendritic parameters from the saline-conditioned and saline homecage mice 
were compared using unpaired t tests. Sholl analysis was evaluated using two-way repeated 
measures ANOVA, with factors of radius and treatment group, followed by post-hoc 
Tukey’s testing for the morphine CPP study, or post-hoc Sidak’s testing for the saline CPP 
control study, to compare the number of intersections at each radius level. In secondary 
analyses, the Pearson’s r Correlation test was used to determine correlations between 
preference score and morphological variables. 
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2.3 Results 
 2.3.1 Mice express a conditioned place preference after four morphine-context 
pairings 
Mice were trained for 8 days, alternating every day between morphine-context or 
saline-context exposures. Two-way repeated measures ANOVA showed a significant 
interaction between time and morphine treatment [F (1, 14) = 5.7, p<0.05], a main 
effect of time [F (1,14) = 14.5, p<0.01], and a main effect of morphine treatment [F (1, 
14) = 9.6, p<0.01] on preference score. Post-hoc testing revealed that the morphine-
conditioned group had significantly higher preference scores (p<0.01), with a mean 
score of over 200 sec, than the saline-conditioned group after conditioning on day 9 
(Figure 3). Mice that were administered saline every day did not demonstrate a place 
preference. 
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Figure 3:  Morphine 10 mg/kg s.c. induces conditioned place preference. Saline 
conditioned place preference (CPP) mice were given saline injections s.c. daily, while 
morphine CPP mice were given saline or morphine 10 mg/kg s.c. on alternating days. 
Injections were given before daily conditioning sessions during which mice were confined 
to a saline-associated or morphine-associated chamber for 50 minutes. After 8 days of 
conditioning, mice were tested to determine how many seconds they spent in each chamber 
when both chambers were accessible. Acquisition of CPP was assessed using a preference 
score, calculated by subtracting time spent in saline chamber from time spent in morphine 
chamber. **p<0.01  
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A separate study was performed to compare a saline conditioned to a saline 
homecage group. A paired t-test comparing preference scores of the control study 
saline-conditioned mice before (mean + SEM: 59.4 + 58.6) and after conditioning 
(mean + SEM: 120.6 + 59.1) showed that they did not develop a significant place 
preference.  
 2.3.2 Acquisition of morphine CPP increases dendritic complexity of neurons in 
the NAc core 
We assessed dendritic complexity by measuring the mean total dendritic length, 
mean total dendritic count, and mean Sholl dendritic intersections of NAc core and 
shell MSNs from saline-conditioned, morphine-conditioned, and morphine homecage 
mice (Figure 4). Total dendritic length is defined as the sum of the length of all dendritic 
trees on an MSN. One-way ANOVA showed a significant effect of treatment group on 
total dendritic length in the NAc core [F (2, 20) = 6.5, p<0.01]. Post-hoc testing 
revealed that NAc core MSNs of the morphine-conditioned group had 20% longer total 
dendritic length than those of the morphine homecage (p<0.05) and saline-conditioned 
(p<0.05) groups (Figure 5A). There were no significant effects of treatment group on 
total dendritic length in the NAc shell (Figure 5C).  
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Figure 4: Representative nucleus accumbens medium spiny neuron and its digital 
tracing. (A) 60X photomicrograph of a medium spiny neuron (MSN) in the nucleus 
accumbens (NAc) stained with the Golgi-Cox method. (B) Digital tracing of the same 
NAc MSN. Primary (10) dendrites attach directly to the soma. Secondary (20) dendrites 
branch from primary dendrite bifurcations. Tertiary (30) dendrites branch from 
secondary dendrite bifurcations. Quaternary (40) dendrites branch from tertiary 
dendrites. Quinary (50) dendrites branch from quaternary dendrites.  To examine 
dendritic complexity, a grid of concentric circles of increasing radii is superimposed 
on a neuron’s digital tracing for Sholl analysis. The number of dendritic intersections 
is defined as the number of times each circle is contacted by a dendritic branch. Scale 
bar is 25 μm. 
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Figure 5: Morphine conditioned place preference increases dendritic length and count 
of nucleus accumbens core medium spiny neurons. (A) Mice that acquired morphine 
CPP (morphine CPP) had NAc core neurons with greater dendritic length than both 
mice that were administered morphine without behavioral training (morphine 
homecage) and mice that were administered saline with behavioral training (saline 
CPP). (B) Mice that acquired morphine CPP (morphine CPP) had a greater number of 
dendritic branches on NAc core neurons than saline CPP mice. (C) There was no 
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significant effect of treatment group on dendritic length of NAc shell neurons. (D) 
There was no significant effect of treatment group on dendritic count of NAc shell 
neurons. *p<0.05 
 
Total dendritic count is defined as the sum of the number of dendritic branches on 
accumbal MSNs. One-way ANOVA showed a significant effect of treatment group [F 
(2, 20) = 4.1, p<0.05] on dendritic count in the NAc core. Post-hoc testing revealed that 
the morphine-conditioned group had a 16% higher dendritic count on NAc core MSNs 
(p<0.05) than the saline-conditioned group (Figure 5B). There were no significant 
effects of treatment group on dendritic count in the NAc shell (Figure 5D).  
 A Sholl analysis tabulates the number of intersections that dendrites make with each 
circle in a grid of concentric circles superimposed on an MSN tracing. Two-way 
repeated measures ANOVA showed that there was an interaction effect [F (38, 380) = 
2.1, p<0.001], a main effect of circle radius [F (19, 380) = 381.7, p<0.0001], and a main 
effect of treatment [F (2, 20) = 6.7, p<0.01] on number of intersections in the NAc core. 
Post-hoc testing revealed that the morphine-conditioned group demonstrated more 
intersections in the NAc core than the morphine homecage group at radii of 10 µm 
(p<0.05), 20 µm (p<0.0001), 30 µm (p<0.05), 40 µm (p<0.0001), 50 µm (P<0.01), 70 
µm (p<0.05), and 90 µm (p<0.05).  The morphine-conditioned group had significantly 
more intersections than the saline-conditioned group at radii of 20 µm (p<0.05), 30 µm 
(p<0.01), 40 µm (p<0.01), 50 µm (p<0.01), 60 µm (p<0.05) and 70 µm (p<0.05) in the 
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NAc core. The saline-conditioned group had significantly more intersections than the 
morphine homecage group at one radius of 20 µm (p<0.01) in the NAc core (Figure 
6A). There were no significant effects of treatment group on intersections in the NAc 
shell (Figure 6B). For a summary of representative neurons from each treatment group, 
see Figure 7 (NAc Core) and Figure 8 (NAc Shell). 
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Figure 6: Morphine conditioned place preference increases dendritic complexity of 
nucleus accumbens core medium spiny neurons. (A) Mice that acquired morphine 
conditioned place preference (morphine CPP) had more dendritic intersections on NAc 
core neurons than mice that were administered morphine without behavioral training 
(morphine homecage). Morphine CPP mice had more dendritic intersections than mice 
that were administered saline with behavioral training (saline CPP). Saline CPP mice 
had more dendritic intersections than morphine homecage mice at only one Sholl 
radius. (B) There was no effect of treatment group on dendritic intersections of NAc 
shell neurons. *p<0.05, **p<0.01, and ****p<0.0001 refer to significant differences 
between morphine CPP and morphine homecage. #p<0.05, and #p<0.01 refers to 
significant differences between morphine CPP and saline CPP. ^^p<0.01 refers to a 
significant difference between saline CPP and morphine homecage. 
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Figure 7: Representative Photos and Tracings of NAc Core Neurons. Neurons at 20X 
are shown from the three treatment groups (A) Saline CPP, (B) Morphine Homecage, 
and (C) Morphine CPP. Scale bar in red is 10 μm.  
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Figure 8: Representative Photos and Tracings of NAc Shell Neurons. Neurons at 20X 
are shown from the three treatment groups (A) Saline CPP, (B) Morphine Homecage, 
and (C) Morphine CPP. Scale bar in red is 10 μm. 
 We performed a separate study to examine the effect of exposure to the CPP 
apparatus on dendritic complexity by measuring the mean total dendritic length, mean 
total dendritic count, and mean Sholl dendritic intersections of NAc core MSNs from 
saline-conditioned and saline homecage mice. In the control study, there were no 
significant differences in dendritic length, dendritic count, or Sholl analysis between 
the saline-conditioned and saline homecage groups (Figure 9 & 10). 
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Figure 9: Saline conditioned place preference does not significantly alter dendritic 
complexity or spine density of nucleus accumbens core medium spiny neurons. There 
were no significant morphology differences between mice that received saline 
injections in the homecage and those that received saline injections and conditioned 
place preference training in the following parameters: (A) dendritic length, (B) 
dendritic count, (C) dendritic intersections, (D) spine density. 
 
49 
 
 
 
 Figure 10: Representative Photos and Tracings of NAc Core Neurons. Neurons at 
20X are shown from the two treatment groups (A) Saline CPP, (B) Saline Homecage. 
Scale bar in red is 10 μm. Insets show representative dendritic spine density on single 
dendrites at 60X.  
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 2.3.3 Morphine homecage administration increases spine density in the NAc core, 
while morphine CPP reverses this morphine effect  
We tabulated spine density (number of spines per 10 µm of dendrite) in the NAc 
core of mice from the morphine-conditioned, saline-conditioned, and morphine 
homecage groups. We counted spines on the most highly branched, longest dendritic 
tree as a representative dendritic sample for each neuron. Estimation of spine density 
using a sampling of dendritic segments has been performed by other research groups 
(Brown & Kolb 2001; Juarez et al. 2011). One-way ANOVA showed a significant 
effect of treatment group on spine density in the NAc core [F (2, 20) = 17.5, p<0.0001]. 
Post-hoc testing revealed that the morphine homecage group had significantly higher 
spine density than the morphine-conditioned group (p<0.01) and saline-conditioned 
group (p<0.0001) in the NAc core (Figure 11 & 12).  
 To examine the effect of CPP training and exposure to the CPP environment on 
spines, we ran a separate study using saline-conditioned and saline homecage treatment 
groups.  There were no significant differences in spine density between the saline-
conditioned and saline homecage groups (Figure 9). 
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Figure 11: Morphine homecage administration increases spine density, and morphine 
CPP reverses this effect. Mice that were administered morphine without behavioral 
training (morphine homecage) had neurons with higher spine density than both mice 
that were administered morphine with behavioral training (morphine CPP) and mice 
that were administered saline with behavioral training (saline CPP). **p<0.01, and 
****p<0.0001. 
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Figure 12: Representative Photos of NAc Core Neuron Spine Density. Representative 
dendritic spine density on single dendrites are shown at 60X from the three treatment 
groups (A) Saline CPP, (B) Morphine Homecage, and (C) Morphine CPP. Scale bar in 
red is 10 μm. 
 
 2.3.4 Preference scores were correlated with total dendritic length and number of 
dendritic intersections in the NAc core  
 As a follow-up to our findings in the NAc core, we used the Pearson’s R correlation 
test to examine correlations between behavioral preference scores of individual mice 
from the saline-conditioned (n=8) and morphine-conditioned (n=8) groups and 
morphological measures of the NAc core. There were many significant correlations 
between CPP preference score and dendritic length and CPP preference score and 
number of intersections at multiple radii (Figure 13). There were no correlations 
between preference score and dendritic count or spine density. The results of the 
53 
 
significant correlations are presented in Table 2. No correlations were performed in 
mice from the CPP control study because no differences were found between groups. 
 
Figure 13: Measure of morphine conditioned place preference is positively correlated 
with dendritic length and dendritic complexity of medium spiny neurons in the nucleus 
accumbens core. (A) Preference scores of individual mice that underwent behavioral 
training for conditioned place preference were positively correlated with total dendritic 
length of medium spiny neurons in the nucleus accumbens core of the same mice. (B) 
Preference scores of individual mice that underwent behavioral training for conditioned 
place preference were positively correlated with number of dendritic intersections of 
medium spiny neurons in the nucleus accumbens core of the same mice. 
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Table 2: Nucleus Accumbens Core Dendritic Morphology Variables Correlated 
with Preference Scores – Correlation Coefficients 
Dendritic Length r = 0.5873* 
Intersections at 10 µm r = 0.0486 
Intersections at 20 µm r = 0.4500 
Intersections at 30 µm r = 0.4208 
Intersections at 40 µm r = 0.6472** 
Intersections at 50 µm r = 0.5576* 
Intersections at 60 µm r = 0.6057* 
Intersections at 70 µm r = 0.5468* 
Intersections at 80 µm r = 0.3962 
Intersections at 90 µm r = 0.5555* 
Intersections at 100 µm r = 0.5295* 
Intersections at 110 µm r = 0.5660* 
Intersections at 120 µm r = 0.3402 
Intersections at 130 µm r = 0.1597 
Intersections at 140 µm r = 0.0877 
Intersections at 150 µm r = 0.1402 
      *p<0.05, **p<0.01 
 
2.4 Discussion 
We found that NAc core neurons of morphine-conditioned mice had longer total 
dendritic length and more dendritic intersections than neurons of both saline-
conditioned and morphine homecage mice. Additionally, NAc core neurons from 
morphine-conditioned mice had significantly more dendritic branches than those from 
saline-conditioned mice. There were no significant differences in NAc shell dendritic 
complexity between treatment groups. The control study showed no difference between 
the saline-conditioned and saline homecage groups for any dendritic morphology 
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parameters in the NAc core, suggesting that our CPP procedure itself does not produce 
dendritic effects. The measures of total dendritic length and intersections in the NAc 
core were both significantly positively correlated with preference scores of saline-
conditioned and morphine-conditioned mice, suggesting that conditioned opiate reward 
is associated with increased dendritic complexity in the NAc core.  
In a previous study, we found that extinction of morphine CPP was associated with 
decreased dendritic complexity of NAc core, but not shell, neurons (Leite-Morris et al. 
2014).  The current study’s results support the hypothesis that morphine conditioning 
reshapes dendrites in the NAc core, a key region that processes drug reward, and that 
extinction of morphine conditioning reverses these dendritic changes. The CPP control 
study confirms that these changes in the NAc core are not simply due to exposure to 
CPP training, but to learning induced specifically by morphine reward. These findings 
show how opiate administration combined with addiction-related learning reshapes 
neurons and alters circuitry-level structures that integrate reward responses. 
Additionally, our results show that animals in the morphine homecage control group 
had greater spine density in the NAc core than either the saline-conditioned or the 
morphine-conditioned group. These results indicate that the main effect of four 
morphine administrations on alternating days is to increase spine density on NAc core 
dendrites and that morphine administration in combination with conditioning reverses 
this effect.  
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Our findings extend a body of important work examining the effect of morphine 
administration on NAc neuron morphology. Drugs of abuse including cocaine, 
amphetamines, and nicotine increase spine density and dendritic complexity in the NAc 
shell and core, while ethanol reduces spine density there (Robinson & Kolb 2004; Zhou 
et al. 2007). Chronic experimenter-administered or self-administered morphine has no 
effect on NAc MSN morphology, but after days to months of withdrawal, dendritic 
complexity and spine density in the NAc shell decreases (Robinson & Kolb 1999; 
Robinson et al. 2002; Spiga et al. 2010). Although not statistically significant, the 
morphine homecage group in our study had decreased NAc shell mean dendritic length 
and number versus saline-conditioned controls. Perhaps, if we used the chronic high 
dose morphine administration profile of Robinson’s group, this outcome could have 
been statistically significant in the shell. Our study differs from previous studies that 
gave two weeks or more of daily 10 mg/kg or higher doses because we administered 
only four 10 mg/kg doses of morphine on alternate days, followed by two days of 
withdrawal, to produce changes in accumbal MSN morphology. In our study, four 
doses of morphine led to increased NAc core spine density, while morphine in 
combination with CPP had the opposite effect on spine density. Our effects may be 
different from previous studies’ because they used daily large amounts of morphine 
over longer periods of time, and focused on the shell. Our major finding is that the 
interaction of morphine administration and CPP training has specific effects on 
dendritic complexity that are different from the effects of morphine administration 
alone.   
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It is important to determine not only how a drug itself affects a user, but also to 
determine how the drug interacts with learning processes in the brain to produce the 
behaviors that are characteristic of addiction. The exact relation of a neuron’s 
morphology to synaptic signal strength is not well understood, but there is evidence 
that morphological changes may mediate behavior associated with addiction and 
learning.  Our finding that the specific effect of morphine reward learning is to increase 
dendritic length and intersections is consistent with previous findings that learning 
alters neuronal morphology. Cognitive performance was differentially correlated with 
dendritic length in different sets of murine frontal cortical neurons (Comeau, 
McDonald & Kolb 2010). Similar to the correlation we found, a positive correlation 
was found between a measure of morphology, spine density in the NAc, and place 
preference score using cocaine, an addictive stimulant drug (Marie, Canestrelli & 
Noble, 2012). It appears that conditioning with both morphine and cocaine increases 
dendritic complexity in the NAc and could underlie reward learning with these drugs 
of abuse.  
Our finding that the NAc core plays a major role in morphine CPP is supported by 
related research that links the core to drug reward learning. Protein synthesis inhibitor 
injected into the NAc core immediately after CPP training blocks CPP acquisition and 
blocks cocaine CPP-induced increases in spine density in the core and shell (Marie, 
Canestrelli & Noble 2012).  In contrast to the finding that cocaine CPP affected the 
core and shell, we found that morphine CPP affected the core only, not the shell, in 
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terms of morphology. Marie and associates used a stimulant class of drug, which 
probably affects subregions of the NAc differently than morphine. Both cocaine and 
morphine act to increase dopamine levels in the NAc, but by different mechanisms. 
Cocaine blocks reuptake of dopamine into the presynaptic VTA neuron, while 
morphine acts at μ opioid receptors on interneurons to disinhibit VTA neurons.  
Cocaine increases brain-derived neurotrophic factor (BDNF) levels in the NAc, and 
blockade of BDNF gene expression reduces cocaine reward as measured by CPP (Bahi, 
Boyer, & Dreyer, 2008). Infusion of BDNF into the rodent NAc has been shown to 
increase dendritic arborization and spine density (Li, et al., 2012).  Oppositely, 
morphine reduces BDNF levels in the VTA, which causes more VTA phasic burst 
firing of dopamine into the NAc, preferentially activating D1 over D2 receptors in the 
NAc and enhancing morphine reward as measured by CPP. Increasing BDNF levels in 
the VTA impedes morphine reward as measure by CPP (Koo, et al., 2012). Cocaine 
reward depends on a more general, tonic, increase in dopamine levels in the synapses 
at the NAC and on direct effects on BDNF in the NAc. Since cocaine increases BDNF 
directly in the NAc, it should be able to increase dendritic complexity in the core and 
shell. Morphine reward depends on direct effects in the VTA, by increasing the VTA’s 
phasic burst firing and activation of the D1 receptor in the NAc. Therefore, morphine’s 
effect on the NAc may be less direct, and more heavily mediated by the VTA’s firing 
pattern, so that directed VTA firing may impact specific cell types in specific 
anatomical regions of the NAc based on which VTA cells are firing and where their 
projections terminate.  
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Accumbal core and shell dopaminergic innervation is necessary for stimulant CPP, 
but only core dopaminergic innervation is necessary for morphine CPP (Sellings & 
Clarke 2003). Other research also suggests that the NAc core has critical importance in 
reward learning paradigms. As measured by c-Fos expression, re-exposure to 
contingent morphine after withdrawal activates the core, but re-exposure to contingent 
sucrose after sucrose withdrawal does not, meaning that the core is preferentially 
activated by opioid relapse (Madsen et al. 2012). Inactivation of the NAc core by deep 
brain stimulation (DBS) during conditioning blocks acquisition of morphine CPP (Liu 
et al. 2008). Electrolytic lesion of the NAc core, but not of the shell, after morphine 
CPP expression prevents drug-priming induced reinstatement of CPP (Wang et al. 
2008). The entire NAc may be necessary for general reward learning, but the core 
subregion appears to be more crucial for opioid reward learning.  These findings, along 
with our current results and previous findings (Leite-Morris et al. 2014), suggest a 
greater role for the NAc core than the shell in control of morphine conditioning. 
The NAc core’s ability to regulate and control how contextual signals lead to 
reward related motor behavior may play an important role in morphine CPP (Marie, 
Canestrelli & Noble 2012; Ito & Hayen 2011). After acquisition of morphine CPP, 
inhibitory high frequency stimulation (HFS) of the NAc core inhibited the ventral 
pallidum (VP) and inhibited the entire NAc more than HFS of the NAc shell (Hu et al. 
2011). Interference with NAc core function after conditioning sessions attenuates CPP 
acquisition and blocks CPP induced structural plasticity in the entire NAc (Marie, 
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Canestrelli & Noble 2012). The projection from the hippocampus, a region that encodes 
spatial information, to the NAc shell is necessary for context-dependent appetitive 
learning (Ito et al. 2008), but the above data suggest that the NAc core may be able to 
control the activity and morphology of shell MSNs in the context of CPP. The region 
of the VP that the core, but not the shell, projects to is specifically activated during 
drug-seeking behavior, implicating the core-VP projection in drug-related motor 
activity (Root et al. 2012). The core’s control over the shell and the VP places it in a 
position to direct CPP because it could regulate contextual salience signals from the 
shell, and direct motor behavior through the VP. The shell may signal salience, while 
the core may gate it. This idea is reflected in Ito and Hayen’s (2011) proposal that the 
NAc core is a relay station that selects which limbic and cortical inputs will drive 
behavior, and that the core has a regulatory role over the shell through inhibitory 
efferents. If the core is the major accumbal integration site, and must be functional 
immediately after conditioning sessions to allow for CPP acquisition, the core could 
serve a memory consolidation function in CPP. Research has linked increased dendritic 
length in rats to enhanced memory retention in spatial learning (Vollala, Upadhya & 
Nayak 2011). The increased dendritic complexity of NAc core MSNs found in our 
study may represent integration and memory consolidation of spatial learning and 
motor behavior in the morphine CPP context. 
In this study, we found that morphine administration was linked to increased spine 
density of NAc core neurons. Mu-opioid receptor activation causes attenuation of 
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excitatory and inhibitory presynaptic input onto MSNs, but increases their intrinsic 
excitability, and this combination could lead to overall increased output by increasing 
the signal-to-noise ratio (Ma, et al., 2012). An increase in spines means an increase in 
possible post-synaptic zones, as spines are regions where excitatory synapses usually 
occur (Bosch & Hayashi, 2012). We did not measure complete synapses, but if the 
morphine-induced increased spine density does reflect an increased number of 
excitatory synapses in the NAc core, the neuron could be more excitable. This may lead 
neurons to become more active in reaction to surrounding sensory input from the limbic 
system, thus increasing the salience of cues and environment. Elaboration of the 
dendritic tree after morphine CPP may decrease overall excitability by increasing 
capacitance and thus low-pass filtering (Shepherd, 2008). The dendritic length is 
increased after morphine CPP, but the number of spines is the same between the 
morphine homecage and morphine CPP groups, meaning the number of synapses 
hasn’t changed, but are possibly more spread out.  
We did not specifically count branch points, but branch points should be increased 
in mice that acquire morphine CPP since they have more dendritic branches. Because 
dendrites on either side of branch points have mismatched radii, they will have 
mismatched input resistance. A current traveling from a smaller to a larger dendrite 
will produce a smaller voltage change in the larger dendrite, leading to signal 
attenuation at branch points (Ferrante et al., 2013). Possibly, more excitatory synapses 
would have to be activated on a highly branched versus a less branched dendrite in 
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order to excite a neuron. On the other hand, having more branches also means a greater 
separation of synapses. This is important because synapses that simultaneously fire on 
the same dendrite will result in sublinear summation of the signal (Spruston, 2009). 
Depolarization of the membrane reduces the driving force for depolarizing ions to 
move into the dendrite; essentially, the ions don’t feel the drive to flow into the dendrite 
at point 2 as much as usual since they’re already doing so and reaching toward their 
equilibrium at point 1. When synapses are on different dendrites, the summation of 
signals is more linear because a change in the driving force across the membrane of 
one will not affect the other (Spruston, 2009). This means that synapses activated at the 
same time on different dendrites have the potential to produce a stronger signal than 
synapses activated on the same dendrite.  
The CPP task requires animals to differentiate between two similar environments 
and associate only one of them with morphine. It is possible that morphology changes 
in mice that acquire CPP make it possible for the NAc MSNs to become excited by 
only the right integration of inputs that indicate the exact specifications of the morphine 
environment, so that the MSNs won’t become excited by a very similar input from the 
saline environment. So, spreading out the synapses, adding dendritic membrane and 
increasing branching may make it harder for neurons to become excited after exposure 
to very similar environments. In this scenario, only the morphine-associated chamber 
can excite the MSN by coincident activation of synapses on multiple dendrites that can 
overcome both branch point signal attenuation and increased capacitance.  
63 
 
In summary, morphine may change the morphology of NAc core neurons so they 
can encode salience of surrounding cues by being more active in response to increased 
synaptic inputs. Then, in the course of morphine CPP training, the NAc core neurons 
must differentiate between reward-associated and neutral contexts. The NAc core may 
encode these differences by increasing dendritic complexity and branching so that 
overall excitability is decreased, allowing only the specific inputs from the environment 
associated with morphine reward to excite NAc core neurons in the mesocorticolimbic 
reward pathway. It is also possible that the NAc core gets activated by the saline 
environment specifically, and then mediates CPP behavior that induces the mouse to 
move away from that environment, and toward the preferred one. 
Results from the current scientific literature can be utilized to investigate 
mechanisms that govern the effect of morphine CPP on MSNs in future studies. 
Limitations of the present study include that we did not assess either neuronal activity 
or address underlying mechanisms of structural changes.  Future studies could measure 
how morphine CPP alters electrophysiological parameters of NAc core MSNs, and how 
those parameters are associated with morphology. We did not differentiate between 
dopamine receptor D1 and D2 containing MSNs, which project to different brain 
regions that may be related to the dorsal striatum’s D1 direct and D2 indirect pathways 
of movement (Smith et al. 2013). Cocaine-induced changes in morphology 
differentially affect the electrophysiological properties of D1 and D2 MSNs (Smith et 
al. 2013). Because dopamine receptor type has connectivity and functional 
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consequences, future studies should compare morphology of D1 and D2 labelled NAc 
MSNs. Furthermore, it would be instructive from a connectivity perspective to know 
how morphine CPP changes morphology in the other brain regions of the mesolimbic 
dopamine pathway such as the prefrontal cortex, hippocampus, and amygdala. Future 
studies could use other methods to label individual neurons using fluorescent 
compounds that can be visualized by the confocal method to confirm the results found 
here.    
 In conclusion, morphine in conjunction with CPP behavior has unique effects on 
NAc morphology that morphine administration alone or exposure to the CPP training 
apparatus alone does not. Our study provides another example of how drug 
administration along with addiction-related learning reshapes neurons and alters 
circuitry-level structure. Such neural changes may be responsible for the long-term 
craving and relapse associated with re-exposure to drug cues and contexts and could be 
a target for intervention in opioid addiction.
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Chapter 3: Extinction of opiate reward reduces dendritic arborization and c-Fos in 
the nucleus accumbens core 
 
Data presented in this chapter were published in the following manuscript: 
 
Leite-Morris KA, Kobrin KL, Guy MD, Young AJ, Heinrichs SC, Kaplan GB 
Behavioural Brain Research (2014) 263: 51-9 
 
Abstract 
Recurrent opiate use combined with environmental cues in which the drug was 
administered provokes cue-induced drug craving and conditioned drug reward. Drug of 
abuse craving is frequently linked with stimuli from a prior drug-taking environment via 
classical conditioning and associative learning. We modeled the conditioned morphine 
reward process by using acquisition and extinction of conditioned place preference (CPP) 
in C57BL/6 mice. Mice were trained to associate a morphine injection with a drug 
context using a classical conditioning paradigm. In morphine conditioning (0, 0.25, 0.5, 
1, 5, or 10 mg/kg) experimental mice acquired a morphine CPP dose response with 
10mg/kg as most effective. During morphine CPP extinction experiments, mice were 
divided into three test groups: morphine CPP followed by extinction training, morphine 
CPP followed by sham extinction, and saline controls. Extinction of morphine CPP 
developed within one extinction experiment (4 days) that lasted over two more trials 
(another 8 days). However, the morphine CPP/sham extinction group retained a place 
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preference that endured through all three extinction trials. Brains were harvested 
following CPP extinction and processed using Golgi-Cox impregnation. Changes in 
dendritic morphology and spine quantity were examined in the nucleus accumbens (NAc) 
Core and Shell neurons. In the NAc Core only, morphine CPP/extinguished mice 
produced less dendritic arborization, and a decrease in neuronal activity marker c-Fos, 
compared to the morphine CPP/sham extinction group. Extinction of morphine CPP is 
associated with decreased structural complexity of dendrites in the NAcCore and may 
represent a substrate for learning induced structural plasticity relevant to addiction. 
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3.1 Introduction 
 Repeated intake of opiates can transition rapidly into drug addiction and its long-
term sequelae including drug overdose and death (Compton & Volkow, 2006).  Drug abuse 
craving linked with stimuli from a prior drug-taking environment occurs through classical 
conditioning and associative learning.  During drug abstinence, cues and contexts from the 
drug-related environment evoke memories of prior drug reward resulting in uncontrolled 
drug abuse (Robinson & Berridge, 2003; Shaham et al., 2003).  Reward learning 
strengthens the association between the unconditioned stimulus (e.g. drug of abuse) and a 
conditioned cue or context, while extinction learning weakens that association (Quirk & 
Mueller, 2008; O’Brien et al., 1993).  In humans, extinction therapy is used to combat 
relapse by repeatedly exposing a drug addicted individual to drug cues in a drug-free state, 
which weakens the conditioned craving response elicited by the cue (Epstein et al., 2009).   
 The nucleus accumbens core (NAc Core) and other neural substrates have been 
associated with drug memories linked to contextual cues (Russo et al., 2010).  Substances 
of abuse act partly through the mesolimbic dopamine system and integrate reward 
information in the nucleus accumbens (NAc).  Most of the neurons within the NAc are 
medium spiny neurons (MSNs) that receive excitatory inputs from the prefrontal cortex, 
hippocampus, basolateral amygdala, and thalamus (Lüscher & Malenka, 2011).  The 
majority of excitatory afferents synapse on dendritic spines in MSNs (Spiga et al., 2005).  
Excitatory synapses in the NAc can serve as sites of glutamate-induced synaptic plasticity, 
resulting in neural correlates of memory including long-term depression and long-term 
potentiation, which can lead to structural changes in neurons (Sesack & Grace, 2010).  
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 We used a translational animal model of conditioned place preference (CPP) and 
extinction learning to emulate extinction learning in the clinic (Tzschentke, 2007; Sakoori 
& Murphy, 2005; Kalivas & Volkow, 2005).  The CPP model was used to associate the 
rewarding and motivational value of morphine with a drug-paired context.  We 
extinguished this conditioned reward by repeatedly exposing mice to the previously drug-
paired context in a drug-free state.  Extinction lead to the reduction of conditioned 
responding because the unconditioned stimulus, the drug, was no longer associated with 
the conditioned stimulus (Sakoori & Murphy, 2005; Kalivas & Volkow, 2005).   
   Addiction to opiates and other drugs of abuse is thought to alter dendritic 
arborization and spine density (Russo et al., 2010; Ballesteros-Yáñez et al., 2007; Diana, 
et al., 2006; Li et al, 2007; Kasture et al., 2009; Robinson & Kolb, 1999; Robinson et al., 
2002; Shen et al., 2008; Shen et al., 2009; Sklair-Tavron et al., 1996; Spiga et al., 2005).  
Changes in dendritic spine size, shape, and number are associated with the strength of 
synaptic transmission and the extent of experience-dependent neural plasticity (Caroni, 
Donato, & Muller, 2012). In particular, chronic exposure to experimenter-administered 
morphine followed by one month of withdrawal decreased the complexity of dendritic 
branching and the number of dendritic spines on medium spiny neurons (MSN) in the NAc 
Shell (Shen et al., 2009).  Moreover, in vitro studies revealed that post-synaptic receptors 
bound to morphine were minimally internalized and produced subsequent collapse of 
dendritic spines resulting in a significant decrease in spine density (Liao et al., 2007).  This 
withdrawal of dendritic surface from reduction in spine density was hypothesized to lead 
to reductions in short-term indices of neural plasticity including excitatory glutamatergic 
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signaling and electrophysiological measurements of membrane excitability (Liao et al., 
2007).  No previous studies have characterized structural plasticity associated with the 
extinction of conditioned opiate reward.  In this investigation, we provide the first analysis 
of dendritic arborization, dendritic spine quantity, and neuronal activity marker c-Fos in 
the context of morphine CPP extinction.  
 Our hypothesis is that structural plasticity of MSNs in the NAc is altered by 
extinction of morphine CPP.  Characterizing accumbal subregional changes in dendritic 
arborization, spine quantity, and c-Fos neuronal activity underlying morphine CPP 
extinction will contribute to understanding which neural substrates and synaptic structural 
changes are linked to opiate addiction.  These findings will lead to the development of 
efficacious treatment approaches for opiate addiction in humans. 
 
3.2 Materials and Methods 
 3.2.1 Animals 
 Male C57BL/6 mice from Charles River Laboratories (Raleigh, NC) were 6-8 
weeks of age and 24-26 g during the experiments. Mice were acclimated to a 12 hour 
light/dark cycle for 5 days before testing during the light cycle. C57BL/6 mice were chosen 
because of their sensitivity to morphine’s stimulant, sensitizing (Leite-Morris et al., 2010), 
and rewarding effects (Kaplan et al., 2003; Heinrichs et al., 2010). The total number of 
mice used was: morphine CPP dose response study (n = 48) and morphine CPP and 
extinction study (n =48). Mice in the CPP/extinction studies were assigned to Golgi-Cox 
staining (n=21) and c-Fos immunohistochemistry (n=24). Three mouse brain samples from 
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the Golgi group were excluded due to insufficient staining. Animal testing was performed 
in a facility approved by the Association for the Assessment and Accreditation of 
Laboratory Animal Care and approved by the Institutional Animal Care and Use 
Committee of the VA Boston Healthcare System. All procedures were approved by the VA 
IACUC. 
 3.2.2 Drug Administration 
 Morphine sulfate (Sigma-Aldrich, St. Louis MO) was dissolved in saline (0.25, 0.5, 
1, 5 and 10 mg/kg) and a subcutaneous (SC) injection was administered in all experiments.  
Morphine dosage, time course of effects, and the SC route of administration were selected 
based on several studies including our previous studies (Spiga et al., 2005; Caroni et al., 
2012; Liao et al., 2007) showing efficacy in altering drug reward.   
 3.2.3 Morphine Conditioning and Extinction 
 Acquisition, expression, and extinction of morphine conditioned place preference 
(CPP) were accomplished over a 25 day place conditioning and extinction protocol that is 
described and schematically presented in Figure 14. 
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Figure 14: Experimental design for morphine conditioned place preference (CPP) and 
extinction training. On Day 1 mice were tested for an unconditioned place preference. 
During CPP development (days 2-9), mice were administered either morphine and 
confined to one conditioning chamber, the conditioned stimulus + (CS+) or saline and 
confined to the other conditioning chamber, the conditioned stimulus - (CS-). On Day 10 
tests for expression of CPP were performed. Mice were trained during three separate 
extinction trials I (days 11-14), II (days 16-19), and III (days 21-24). During extinction 
trials mice were placed in the CS+ chamber without morphine, and on alternate days in the 
CS- chamber without morphine. Tests for CPP expression were performed after each 
extinction trial on days 15, 20, and 25. On day 25, one hour after the last preference test, 
mice were euthanized and brains were harvested for c-Fos immunohistochemistry. On day 
26 mice were euthanized and brains were harvested for Golgi-Cox staining. 
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  3.2.3.1 Conditioning Apparatus 
  The place conditioning environment consists of two black conditioning 
chambers of equal size (16.75 x 12.70 cm) separated in the middle by a (7.25 x 12.70 cm) 
gray chamber with automated doors that connect to the black conditioning chambers 
(Mouse Place Preference; Med Associates, St. Albans, VT). The black chambers each have 
distinct flooring with contextual differences (stainless steel grid vs. bars) along with 
different spatial orientations (one chamber positioned on the left vs. one chamber 
positioned on the right of the gray chamber).  
  3.2.3.2 Conditioning Procedures 
  Two separate studies were performed using the same conditioning 
procedure.  First, a morphine dose response study was performed to determine the optimum 
dose of morphine that would induce CPP in our behavioral testing environment.  In this 
dose response study, 48 mice were injected with either saline or 0.25, 0.5, 1.0, 2.5, or 10 
mg/kg morphine s.c. (n=8 per group) and were sacrificed after conditioning.  Second, an 
extinction study consisted of three groups: a saline control group (n=15), a morphine/sham 
extinction group (n=24), and a morphine/extinction group (n=14).  In this second study, 
mice received morphine doses of 10 mg/kg during CPP acquisition and underwent 
extinction training on days 11-25 after conditioning. The following paragraphs describe 
the conditioning procedures all mice underwent during the dose-response and CPP 
extinction studies. 
 Prior to acquisition of morphine CPP, mice were habituated to the entire apparatus 
on day 1, for 15 min, and were allowed to explore the three chambers.  Movement 
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throughout the chambers was tracked by the interruption of infrared beams located along 
the perimeter of the apparatus that tracked movement over time; time spent in each chamber 
was calculated from the time tracking data.  Mice that exhibit an unconditioned preference 
or stay over 67% of the time in one conditioning chamber over the other are considered 
biased and were excluded from the study (Heinrichs et al., 2010).  Only n = 3 mice with an 
unconditioned preference were excluded from the study and only unbiased mice were 
included in these experiments.  
 During the conditioning phase (days 2-9), mice were injected with morphine on 
days 2, 4, 6 and 8, or with saline on days 3, 5, 7 and 9. The control group (saline) was 
injected with saline on all conditioning days 2-9. All mice were confined for 50 minutes to 
the assigned conditioning chamber immediately after injection. The design was balanced 
so that half of the morphine injected mice were conditioned to associate morphine with the 
left conditioning chamber, and half with the right. The chamber paired with morphine 
injection is labeled the conditioned stimulus positive (CS+). The chamber paired with 
saline is labeled the conditioned stimulus negative (CS-).  Half of the saline injected mice 
were used as a control for the morphine injected mice conditioned to the left chamber (left 
CS+ control), and half were used for those conditioned to the right chamber (right CS+ 
control).   
 Mice were evaluated during the preference test for successful conditioning on day 
10.  Subjects were placed in the middle chamber of the apparatus and allowed to move 
between the two conditioning chambers over 15 min.  CPP was defined as a difference in 
the time spent in one conditioning chamber compared to the other, based on several studies 
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and our previous work (Kaplan et al., 2003; Heinrichs et al., 2010; Paolone et al., 2009).  
CPP was determined by subtracting the time spent in the saline-paired chamber from the 
time spent in the morphine-paired chamber (or assigned control chamber for mice that were 
only trained with saline) to generate a difference score.  In our paradigm we are measuring 
motivational effects of drug conditioning. Other behaviors could be measured that 
influence outcome, such as locomotor activity (Huston et al., 2013).  However, in our 
experimental design we focused only on place preference.  
  3.2.3.3 Extinction Learning Procedures     
  All mice subsequently used for neurobiological analyses in the extinction 
study underwent three extinction training sessions, Extinction I (days 11-14), Extinction II 
(Days 16-19), and Extinction III (Days 21-24).  Mice were not injected with any agents 
during extinction procedures.  All saline conditioned mice (n=15) and half of the morphine 
conditioned mice (Morphine/Extinction group; n=14) were confined to CS+ or CS- 
chambers for 50 minutes on alternate days.  The purpose of active extinction training in 
morphine conditioned mice was to diminish the predictive value of tactile and contextual 
cues (CS+) associated with conditioned place preference relative to the baseline established 
by morphine naïve (saline) controls in which a place preference was never conditioned.  
The other half of the morphine conditioned mice (n=15) underwent a sham extinction 
(n=16) to serve as a control group for the morphine/extinction group. The sham extinction 
group underwent morphine CPP acquisition, but not extinction procedures.  During sham 
extinction mice were confined for 50 minutes daily to a separate chamber not associated 
with CPP training, in the same room by the same handler.  All mice underwent preference 
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tests after each extinction training session (I, II, and III) on days 15, 20, and 25. Mice were 
euthanized one hour after Extinction III on day 25 for c-fos staining, or one day after 
Extinction III on day 26 for Golgi-Cox staining. 
 3.2.4 Dendritic Morphology Procedures 
 On day 26, mice were anesthetized using a lethal dose of sodium pentobarbital.  
Brains were removed, then frozen and embedded in Tissue Freezing Medium (Triangle 
Biomedical Sciences, In., Durham, NC, USA).  Coronal sections (100 µm) of the NAc 
Core and NAc Shell were sliced using a cryostat microtome (Leica Microsystems Inc., 
Buffalo Grove, IL) according to a mouse brain atlas (Franklin & Paxinos, 2007).  NAc 
Core and NAc Shell sections were collected and mounted on chrome alum gelatin coated 
slides and stained according to the Golgi staining kit manual (FD NeuroTechnologies, Inc., 
Catonsville, MD). 
 Dendritic analyses were performed in the NAc Core and NAc Shell, on the 
following three treatment groups: morphine/sham extinction (n=8), morphine/extinction 
(n=6), and saline (n=7).  In each brain region 5 MSNs from 3-4 sections were visualized at 
60x magnification (Figure 15A) with an Olympus BX51 bright field microscope interfaced 
with a color digital camera (MicroFire; Optronics, Goleta, CA).  MSNs were manually 
traced (Figure 15B) using Neurolucida software (MBF, MicrobrightField Inc., Williston, 
VT).  Tracing of dendrites were from neurons located in the NAcCore from Bregma 1.54 
to 0.98 mm and in the NAcShell from Bregma 1.54 to 0.98 mm.  Based on the tracings, 
dendritic spine density (number of spines/10 µm of dendrite), dendritic branching, 
dendritic length, and Scholl analysis data were calculated using Neurolucida Explorer 10.3 
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(MBF Bioscience, MicroBrightField Inc., Williston, VT).  Sholl analysis software was 
used for obtaining a grid of concentric circles that are spaced 10 µm apart and 
superimposed on top of a neuronal tracing (Figure 15C).  The center circle is placed around 
the soma. The number of dendrites intersecting with each circle was tabulated to determine 
the extent of dendritic arborization. The number of spines on dendrites within each ring 
was tabulated to determine the distribution of spines.  In a separate analysis, mean spine 
density, total dendritic length from the first to the fourth order per neuron, and total number 
of dendritic branches per neuron was determined.    
 
Figure 15: Neuronal tracing of a nucleus accumbens core medium spiny neuron. (A) 
Photomicrograph at 60X magnification, of the soma and dendrites of a medium spiny 
neuron from the NAc Core stained with the Golgi-Cox method. (B) Tracing of the dendrites 
and spines from the same neuron. Primary (1⁰) refers to branching directly from the soma, 
secondary (2⁰) dendrites branches from a bifurcation of the 1⁰ dendrite, and tertiary (3⁰) 
refers to a dendrite branching from a bifurcation of the 2⁰ dendrite. (C) Sholl analysis of 
the traced neuron was used to measure the number of intersections dendrites make with a 
grid of concentric circles centered on the soma and to count the number of spines within 
each concentric circle. 
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 3.2.5 c-Fos Procedures 
 c-Fos protein expression is known to peak at approximately 60 to 120 minutes 
following an acute morphine injection (Leite-Morris et al., 2004) therefore, mice were 
sacrificed one hour after the final post-extinction preference test (day 25).  Mice were 
anesthetized with a lethal dose of pentobarbital sodium and transcardiac perfusion was 
performed with 4% paraformaldehyde.  Brains were removed, post-fixed, frozen in 
isopentane, and stored at  
-35°C until sectioned.  Coronal brain sections (40 µm) were collected from the NAc Core 
and NAc Shell, according to the mouse brain atlas, as stated in section 3.2.4 (Franklin & 
Paxinos, 2007).  Brain sections were rinsed in PBS, and incubated in 1.5% goat serum for 
30 min at room temperature.  Immunohistochemistry was performed using our previously 
described floating method (Leite-Morris et al., 2004), using rabbit affinity-purified 
polyclonal antibody raised against the amino terminus of the c-Fos peptide at a 1:10,000 
dilution (Santa Cruz Biotechnology, Inc., Santa Cruz, CA).  Sections were washed and 
incubated with biotinylated goat anti-rabbit secondary antibody at a 1:2,000 dilution.  
Immunoreactivity was visualized using the biotin-streptavidin technique (ABC Staining 
System, Santa Cruz Biotechnology, Inc. Santa Cruz, CA) with metal-enhanced 3, 3’ 
diaminobenzidine as the chromagen (Pierce, Rockford, IL).  
 c-Fos analyses were performed on the following three treatment groups: 
morphine/sham extinction (n=8), morphine/extinction (n=8), and saline (n=8).  
Quantitative measurement was performed using a computer-assisted image analysis system 
consisting of an Olympus BX51 bright-field microscope interfaced with a color digital 
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camera (Micro Fire; Optronics) and Image-Pro Plus image processing & analysis software 
(version 6.3; Media Cybernetics, Silver Spring, USA).  Blinded analysis was performed on 
images captured at 10x magnification.  A 200 x 200 µm box was placed inside the NAc 
Core or NAc Shell with coordinates according to the stereotaxic atlas (Franklin & Paxinos, 
2007) and c-Fos positive nuclei within the box were quantified by automated computerized 
counting within a manually set threshold (85-130) for all brain sections.  In the NAc Core, 
the box was placed at Bregma 1.54 to 0.98 mm medial to the anterior commissure, with 
the top horizontal width placed just dorsal to the anterior commissure.  In the NAc Shell, 
the box was placed at Bregma 1.54 to 0.98 mm lateral to the major islands of Calleja and 
the top horizontal width was placed at the dorsal edge and equal height to the anterior 
commissure, with the top of the box extending dorsally at the level of the anterior 
commissure.  In the caudate putamen (CPU) the box was placed at Bregma 1.06 to 1.34, in 
a central area with the top edge of the box at the level of the lateral ventricle.  Bilateral 
totals of c-Fos positive puncta across 6-8 sections from each brain region were averaged to 
create the total count for each mouse.  A pilot study was performed for c-Fos expression in 
mice sacrificed after Extinction I, II, and III.  Changes in c-Fos immunoreactivity did not 
occur until Extinction III. Bilateral totals of c-Fos positive puncta from 6-8 sections in each 
brain region were averaged to create the total count for each mouse.  
 
 3.2.6 Statistical Analysis 
 All data were analyzed using GraphPad Prism 6.0 (GraphPad, La Jolla, CA, USA).  
The place conditioning CS+/CS- difference scores were compared using two-way, repeated 
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measures analyses of variance (ANOVA) employing factors of experimental phase (time) 
and treatment group, followed by a post-hoc Tukey’s multiple comparisons test to assess 
differences between treatment groups at each level of the experimental phase.  All dendritic 
analysis was performed using the total number of mice for Saline (n=7), 
Morphine/Extinction (n=6) and Morphine/Sham Extinction (n=7).  Dendritic intersections 
and number of spines from the Sholl analyses in the NAc Core and NAc Shell were 
compared using two-way ANOVA employing the factors of radial distance from the soma 
and treatment group, followed by a post-hoc Tukey’s multiple comparisons test to assess 
differences between treatment groups overall, and at each level of radial distance.  Data 
from the NAc Core and NAc Shell were analyzed by two-way ANOVA to determine 
differences in spine density (spines/10 µm of dendrite) employing factors of dendritic 
arbor, branches, order, and treatment group, followed by a post-hoc Tukey’s multiple 
comparisons test to assess differences between treatment groups at each dendritic branch 
level. Dendritic length and number of dendritic segments were analyzed by one-way 
ANOVA, followed by post-hoc Tukey’s test. Significance for all analyses was defined at 
the p<0.05 level.  Fos expression in the NAc Core, NAc Shell, and CPU were analyzed 
using one-way ANOVA, followed by a post-hoc Tukey’s multiple comparisons test to 
assess differences between treatment groups.  Significance for all analyses was defined at 
the p<0.05 level. 
 
 
 
80 
 
3.3 Results 
 3.3.1 Effects of morphine on conditioned place preference and its extinction 
 A morphine dose response experiment was performed to determine the optimal 
dose of morphine to induce CPP (Figure 16).  Mice were injected with different doses of 
morphine (0.25, 0.5, 1, 2.5, or 10 mg/kg, s.c.) or saline and underwent acquisition of CPP, 
preceded and followed by pre- and post-conditioning preference tests. Two-way repeated 
measures ANOVA revealed a significant interaction between time and treatment group 
[F(5,42)=4.0, p<0.01], and main effects of time [F(1,42)=36.5, p<0.0001] and treatment 
[F(5,42)=3.3, p<0.05] on preference score, also known as difference score (seconds in CS+ 
minus seconds in CS-).  Post-hoc testing revealed that the mice administered 0.5, 1.0, 2.5 
(p<0.5) and 10 (p<0.001) mg/kg morphine had significantly higher difference scores 
compared to saline treated mice (Figure 16).  Mice administered 1.0, 2.5 (p<0.05), and 10 
(p<0.001) mg/kg morphine had significantly higher difference scores compared to the 
lowest dose 0.25 mg/kg. The 10 mg/kg morphine had significantly higher difference scores 
than the 0.5 (p<0.05) mg/kg morphine group.  Therefore, the 10 mg/kg morphine dose was 
chosen for the morphine induced CPP experiment.  
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Figure 16: Morphine conditioned place preference is dose-dependent. Difference scores 
of mice following s.c. administration of saline or morphine (0.25, 0.5, 1.0, 2.5, 10 mg/kg, 
n=8 per group) were calculated as time spent in morphine associated (CS+) minus time 
spent in the non-morphine-associated (CS-) compartment (mean ±S.E.M.). First, a pre-
conditioning preference test (Pre-test) established baseline compartment preference. 
Second, mice underwent 9 days of conditioning followed by a post conditioning preference 
test (Post-conditioning). Mice conditioned with 0.5, 1.0, 2.5, and 10 mg/kg of morphine 
acquired CPP as evidenced by difference scores that were significantly higher than that of 
saline controls. * p<0.05 compared to the saline group; ***p<0.001 compared to the saline 
group; #p<0.05 compared to the 0.25 morphine mg/kg group; ###p<0.001 compared to the 
0.25 mg/kg morphine group; ^p<0.05 compared to the 0.5 mg/kg morphine group. 
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 In a separate experiment, mice underwent morphine conditioning followed by 
extinction trials.  Preference testing occurred five times during the study: pre-conditioning, 
post-conditioning, and after extinction sessions I, II, and III (Figure 17).  Two-way repeated 
measures ANOVA revealed a significant interaction of treatment and time [F(8,180) =3.4, 
p<0.01], and significant main effects of both time [F(4,180) =7.7, p<0.0001] and morphine 
treatment [F(2, 45) =10.9, p<0.0001] on difference scores.  Post-hoc analysis revealed that 
in the post-conditioning phase, both the morphine/sham extinction (p<0.0001) and 
morphine/extinction groups (p<0.001), exhibit significantly higher difference scores 
compared to the saline group.  Thus, both groups demonstrated the expression of morphine 
place preference. This morphine place preference was then extinguished over three trials. 
Post-hoc testing revealed that morphine/sham extinction mice retained significantly higher 
difference scores after extinction I (p<0.01), II (p<0.01), and III (p<0.01) compared to 
saline mice.  In comparison to morphine/sham extinction mice, morphine/extinction mice 
exhibited significantly lower difference scores after extinction trials I (p <0.05), II 
(p<0.01), and III (p < 0.05).  CPP was extinguished in the morphine/extinction group, as 
post-hoc testing revealed no significant differences in difference scores between this group 
and the saline controls after extinction sessions I, II, and III. 
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Figure 17: Morphine conditioned place preference was extinguished. Difference scores of 
mice following subcutaneous administration of saline or 10 mg/kg morphine were plotted 
as time spent in morphine associated (CS+) relative to non-morphine associated (CS-) 
compartments (mean ± S.E.M.). A pre-conditioning test (Pre) established baseline 
compartment preference. After conditioning procedures a post-conditioning preference test 
(Post) was performed. Tests to determine retention of preference were performed after 
early (Ext I), middle (Ext II), and late (Ext III) extinction trials. The treatment groups are 
as follows: saline (n=15), morphine/sham extinction (n=16), and morphine/extinction 
(n=14). ####p<0.0001 compared to the saline group; ##p<0.01 compared to the saline 
group; ####p<0.0001 compared to the saline group; ^^^p<0.001 compared to the saline 
group; *p<0.05 compared to the morphine/sham extinction group; **p<0.01 compared to 
the morphine/sham extinction group.  
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 3.3.2 Effect of morphine CPP extinction on dendritic arborization in the NAc   
We assessed whether morphine CPP alters dendritic arborization during extinction of 
morphine CPP using a Sholl analysis, which counts the number of intersections that 
dendrites make with each circle in a grid of concentric circles centered on the soma.  Two-
way ANOVA revealed no interaction but a significant main effect of distance from soma 
(increasing circle radius) on number of intersections in the NAc Core [F(9,162)=75.70, 
p<0.0001] and NAc Shell [F(9,162)=71.85, p<0.0001], meaning that the extent of dendritic 
arborization depends on the distance from the cell body.  There was a significant effect of 
treatment group [F(2, 18)=5.35, p<0.05) on dendritic arborization in the NAc Core, but not 
in the NAc Shell (Figure 18).  Post hoc analysis of NAc Core data comparing treatment 
groups showed that the Morphine/Extinction group had a lower total number of 
intersections than the Morphine/Sham Extinction group , but  analysis comparing treatment 
groups at each radius level (number of intersections at each circle individually) showed no 
significant differences at any particular radii. 
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Figure 18: Morphine CPP extinction is associated with a decreased number of dendritic 
intersections per neuron in the NAc core. A dendritic Sholl analysis was performed to 
determine the number of intersections at each concentric circle. The circles are spaced 
10μm apart, with 0μm positioned at the center of the soma. The treatment groups are as 
follows: saline (n=7), morphine/sham extinction (n=8), and morphine/extinction (n=6). 
Five neurons per mouse were evaluated: saline = 35 neurons; morphine/sham extinction = 
40 neurons; and morphine/extinction = 30 neurons. Two-way ANOVA revealed a main 
effect of distance from soma (increasing radius) on number of intersections in the NAc 
Core (p<0.0001) and NAc Shell (p<0.0001). There was a significant effect of treatment 
group (p<0.05) on dendritic arborization in the NAc Core, but not in the NAc Shell. * refers 
to a significant difference (p<0.05) between the morphine/extinction and morphine/sham 
extinction groups. 
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 3.3.3 Effect of morphine CPP extinction on dendritic length and count 
 The mean data for total dendritic length from the first to the fourth order per neuron 
(Figure 19) and for total number of dendritic segments per neuron (Figure 20) was 
compared between the extinction treatment groups.  One-way ANOVA of NAc Core data 
showed that there was a significant effect of treatment group for both length [F(2,18) = 
4.413, p<0.05] and count of dendrites [F(2,18) = 3.978, p<0.05].  Post-hoc testing of the 
NAcCore data showed that the morphine/extinction group had significantly lower total 
dendritic length than either the morphine/sham extinction (p<0.05) or the saline control 
(p<0.05) groups (Figure 19A). The morphine/extinction group also had fewer total 
dendritic segments than the morphine/sham group (p<0.05) (Figure 20A).  One-way 
ANOVA of NAc Shell data showed that there were no significant differences between 
groups for either length or count of dendrites (Figure 19B and 20B). For a representative 
photo summary of the results, see Figures 21 and 22. 
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Figure 19: Morphine CPP extinction was associated with shortened total dendritic length 
in the NAc core (A), but not in the shell (B). The treatment groups were saline (n=7), 
morphine/sham extinction (n=8), and morphine/extinction (n=6). Five neurons/mouse 
were evaluated for a total of saline = 35 neurons; morphine sham extinction = 40 neurons; 
and morphine extinction = 30 neurons. *p<0.05 compared to the morphine/sham extinction 
group; ^p<0.05 compared to the saline group. 
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Figure 20: Morphine CPP extinction was associated with an increased number of dendritic 
branches per neuron in the NAc core (A), but not in the shell (B). The treatment groups 
were saline (n=7), morphine/sham extinction (n=8), and morphine/extinction (n=6). Five 
neurons/mouse were evaluated for saline, morphine sham extinction, and morphine 
extinction. *p<0.05 compared to the morphine/sham extinction group.  
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 3.3.4 Effects of morphine CPP and its extinction on dendritic spines in the NAc  
 The effects of morphine CPP and its extinction on the quantity and distribution of 
dendritic spines in the NAc Core and NAc Shell was determined using Sholl analysis.  
Mean spine density per neuron was quantified and statistically assessed, but there were no 
significant differences in spine density between the treatment groups.  The number of 
dendritic spines within each 10 µm segment (radial distance) from the soma for each 
neuron was counted.  Two-way ANOVA of NAc Core and NAc Shell data revealed that 
there were no interaction effects, no significant main effects of distance from soma, and no 
differences between treatments on the mean number of spines. The treatment groups were 
saline (n=7), morphine/sham extinction (n=8), and morphine/extinction (n=6).  Five 
neurons/mouse were evaluated for a total of saline = 35 neurons; morphine sham extinction 
= 40 neurons; and morphine extinction = 30 neurons.  Data of neurons from the same mouse 
were averaged to create single values for individual mice, so that all comparisons were 
between mice and not between individual neurons.   
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Figure 21: Representative Photos and Tracings of NAc Core Neurons. Neurons at 20X are 
shown from the three treatment groups (A) Saline CPP/Extinction, (B) Morphine/Sham 
Extinction, an d (C) Morphine CPP/Extiction. Scale bar in red is 10 μm. Insets show 
representative dendritic spine density on single dendrites at 60X.  
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Figure 22: Representative Photos and Tracings of NAc Shell Neurons. Neurons at 20X are 
shown from the three treatment groups (A) Saline CPP/Extinction, (B) Morphine/Sham 
Extinction, an d (C) Morphine CPP/Extiction. Scale bar in red is 10 μm. Insets show 
representative dendritic spine density on single dendrites at 60X.  
 
 3.3.5 Effect of morphine CPP extinction on c-Fos protein expression in the NAc  
 c-Fos protein expression was analyzed in the NAc Core, NAc Shell and CPU to 
determine whether CPP and its extinction alter neuronal activation.  One way ANOVA 
revealed a significant main effect of treatment group on c-Fos protein levels in the NAc  
Core [F(2,21) = 4.6, p< 0.05)], but not in the NAc Shell or CPU (Figure 23). Post-hoc 
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analyses of NAc Core data determined that c-Fos protein levels in the morphine/extinction 
group were significantly lower than in the morphine/sham extinction group (p<0.05).  
 
 
 
Figure 23: Morphine CPP extinction has decreased c-Fos protein expression in the NAc 
Core, but not the NAc Shell or CPU. Brains were harvested following the third extinction 
test and c-Fos protein immunoreactivity was measured in the three treatment groups (n=8 
per group): saline, morphine/sham, and morphine/extinction. Data represent the number of 
immunoreactive nuclei (mean +/- SEM) in each brain region.*p<0.05, compared to the 
morphine/sham extinction group. Credit for this figure and all c-Fos work goes to Angela 
Young and Marsha Guy. 
 
 
 
93 
 
3.4 Discussion 
 This study provides evidence that morphine treatment produces dose-dependent 
expression of CPP as measured by a robust difference score during the post-conditioning 
preference test. This morphine place preference was enduring and was retained 15 days 
after drug conditioning in the morphine/sham extinction group (at 10 mg/kg). Following 
extinction procedures, mice repeatedly exposed to the previously drug-paired context 
without morphine demonstrated extinction of this place preference. This extinction 
response developed within 4 extinction trials and continued through 8 and 12 extinction 
trials.  
 We sought to determine whether the shell and core subregions of the NAc were 
involved in the extinction of opiate CPP. The NAc Shell is functionally linked to emotional 
and motivational responses while the NAc Core has been linked to drug memories that are 
associated with environmental cues and is more involved with motor function (Sesack & 
Grace, 2010; Everitt & Robbins, 2005).  The extinction of morphine reward produced 
significant structural changes in dendritic branching across a 100 μm radial distance from 
the soma in the NAc Core, but not in the NAc Shell.  In mice that underwent extinction of 
morphine CPP, the number of NAc Core dendritic intersections, dendritic length, and 
number of dendritic branches/neuron were reduced compared to the morphine CPP/sham 
extinction group. The NAc Core neurons are probably involved in controlling the motor 
behavior required for CPP, but specific functional studies are needed to demonstrate this 
relationship. Previous work showed that opiate withdrawal produced reductions in 
dendritic spine density and dendritic arborization of MSNs in the NAc Shell (Diana et al., 
94 
 
2006; Spiga et al., 2005).  No other studies have yet shown the effects of morphine CPP 
followed by CPP extinction on NAc MSN morphology.  Both the morphine/extinction and 
the morphine/sham extinction groups were in a two week abstinence state at the time of 
mouse euthanasia, yet the sham extinction group did not have a reduction in dendritic 
complexity, while the extinction group did. The morphine/sham extinction group in our 
experiment did not show a reduction in dendritic complexity after the period of withdrawal 
during which the sham extinction occurred.  This suggests that that our dendritic findings 
are not simply due to opiate withdrawal effects, and appear to be related to our training 
paradigms. 
 In the present investigation, regional specificity of neuronal activity was assessed 
by quantifying c-Fos protein, the protein product of the immediate early gene c-fos (Liao 
et al., 2007).  We have previously shown that c-Fos protein can be induced by morphine 
exposure (Leite-Morris et al., 2004) and have designed the present experiments to measure 
c-Fos immunoreactivity after the extinction of CPP.  Morphine-induced c-Fos expression 
in the NAc results from the activation of μ-opioid receptors that disinhibit, and therefore 
increase, VTA dopaminergic signaling in the NAc. Dopamine receptor activation in the 
NAc initiates a cascade of intracellular events leading to c-Fos protein expression 
(Heinrichs et al., 2013).  We provide evidence that extinction of CPP not only alters 
structural plasticity, but also produces significant signaling changes by reducing c-Fos in 
the NAc Core, but not in the NAc Shell or CPU.   The NAc Core structural changes are 
potentially associated with changes in neural cell activation in the NAc Core.  We associate 
this functional decrease in neuronal activity from c-Fos with the decrease in morphological 
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complexity from the neuronal tracing, but no direct correlation was done.  Future studies 
examining morphine CPP extinction should include other neural activity markers, such as 
electrophysiology measures, that more sensitively detect neuronal functional changes.  
 Dendritic morphology contributes to the electrotonic properties of neurons, and 
therefore can affect their activity. We found a retraction of dendritic arborization and 
reduced branching after the behavior of morphine CPP was extinguished. A reduction in 
branching would decrease impedance mismatch, and thus signal attenuation, allowing a 
single from a dendrite to more easily reach the soma and activate output (Ferrante et al., 
2013). The reduced dendritic arborization would reduce capacitance so that an MSN would 
be more easily excited, or less able to perform more complex computations, and therefore 
may not be specifically reactive to one of the environments over the other (Shepherd, 
2008). These neurons with less complex dendritic morphology are more excitable and tend 
to have less ability to produce burst firing in the axon (Mainen & Sejnowski, 1996). This 
burst firing encodes information with more specificity than constant firing (Rolls & Treves, 
2011). Therefore, a more active neuron is not necessarily transmitting more information. 
Bursting may correlate with exposure to a specific input, such as the morphine-associated 
chamber. An easily excitable neuron may react similarly to different inputs, such as the 
neutral and morphine-associated chambers, and possibly would not differentiate as well 
between them. Reduced NAc core MSN dendritic complexity may contribute to CPP 
extinction by allowing MSNs to become equally excited with exposure to both the saline 
and morphine chambers. Without NAc core activation in response to one chamber over the 
96 
 
other, excitation of NAc core MSNs will no longer differentiate the chambers, and the core 
will not be able to drive CPP behavior.  
 This current study highlights that just a few opiate exposures followed by extinction 
training can produce a reduction in accumbal dendritic complexity. Previous studies have 
not examined dendritic morphology extinction training effects in an opiate CPP model.  
However, a reduction of dendritic complexity after extinction training has been 
demonstrated in other animal models, such as fear conditioning/extinction.  Our results are 
consistent with studies demonstrating dendritic remodeling after fear conditioning that is 
reversed by extinction training (Vetere et al., 2011; Lai et al., 2012; Heinrichs et al., 2013).  
These findings suggest that extinction may partially eliminate the original effects of 
conditioning on plasticity in addition to creating a new type of memory, as previously 
believed (Quirk & Mueller, 2008).  Future work could include studies on the time course 
and persistence of morphine CPP extinction, and on structural plasticity in cortical and 
other subcortical brain regions and their underlying molecular mechanisms (Robinson & 
Kolb, 2004).  Understanding such structural mechanisms of opiate CPP and extinction can 
inform future treatment approaches for opiate addicted patients that target plasticity.  
 Our CPP extinction model was designed to emulate cue exposure therapy (CET) in 
humans, an approach that is integrated into mainstream psychosocial treatment in 
addiction.  During CET, a drug addicted person reviews drug-related cues and contexts to 
reduce cue activated emotional responses related to drug craving.  This extinction 
treatment, when integrated with cognitive approaches, was partially effective in clinical 
trials (O’Brien et al., 1993).  Heroin-dependent inpatients randomized to CET showed a 
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significant decrease in physiological reactivity to cues relative to a placebo treatment group 
(Mayet et al., 2005).  After CET, alcohol-dependent patients had decreased over-activation 
in the ventral striatum in response to visual presentation of cues (Vollstädt-Klein et al., 
2011).  Thus, increasing the rate and effectiveness of extinction learning is a highly 
desirable clinical approach for the treatment of opiate addiction and further understanding 
of associated dendritic plasticity changes is central for understanding and improving such 
successful interventions. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
98 
 
Chapter 4: Dopamine D1 receptor activation impedes extinction of morphine 
conditioned place preference and associated changes in dendritic morphology 
 
Data presented in this chapter were prepared as a manuscript: 
 
Kobrin KL, Arena DT, Heinrichs SC, Kaplan GB 
 
Abstract 
 The dopamine D1 receptor (D1R) mediates drug reward and morphology of 
accumbal neurons. We used a morphine conditioned place preference (CPP) mouse 
model to study the role of the D1R in drug-related associative learning and linked 
dendritic morphology changes. To acquire CPP, a morphine-conditioned group received 
saline or morphine 10 mg/kg s.c. on alternate days, while saline-conditioned controls 
received saline on all days, immediately before 8 daily place conditioning sessions. 
Morphine-conditioned mice expressed significantly higher place preference than saline-
conditioned mice. To induce extinction, mice were repeatedly exposed to the place 
conditioning environment in a drug-free state. A control group received saline during 
extinction, while morphine-conditioned mice were divided into three groups that received 
s.c. saline, 0.5 mg/kg D1R agonist SKF81297, or 0.8 mg/kg SKF81297 immediately after 
each extinction session. After every two days of extinction training mice were tested for 
place preference. D1R agonist treatment inhibited extinction of place preference in a dose 
dependent manner. Morphine-conditioned mice treated with 0.8 mg/kg SKF81297 
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injections had a mean place preference score twice as high as that of morphine-
conditioned mice treated with saline. In order to assess morphology, mice were sacrificed 
one day after the final place preference test. Brains were isolated and processed using 
Golgi-Cox staining followed by digital tracing of nucleus accumbens neurons. Neurons 
from morphine-conditioned mice treated with 0.8 mg/kg SKF81297 during extinction 
were prevented from undergoing extinction-related changes, and had more complex 
dendritic arbors, longer dendritic length and higher spine density than morphine-
conditioned mice treated with saline during extinction. 
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4.1 Introduction  
 Opioid misuse and addiction is a rapidly increasing problem that has led to 
widespread distribution of antidote naloxone kits because of the remarkably high rate of 
recent overdose deaths (Khazan, 2014; World Health Organization, 2014). Long-term 
opioid use leads to chronic brain adaptations which underlie uncontrolled and compulsive 
drug-seeking, negatively impacting a person’s health, relationships, and finances 
(Robinson & Berridge, 2003; Kosten & George, 2002). Related cues and contexts will 
become associated with opioids and other drugs of abuse after repeated use, and these 
associations, or triggers, can induce drug craving and relapse in an abstinent individual 
(Franken et al., 1999).  
 The widely utilized animal model of trigger formation, conditioned place 
preference (CPP), can detect the dose-dependent strength of drug reward-associations 
(Leite-Morris et al. 2014; Tzschentke 2007). In the model, drug administration is paired 
with one context, while saline administration is paired with another context. CPP is 
expressed when an animal spends more time in the chamber associated with a drug of abuse 
than in the chamber associated with saline. CPP can be extinguished by exposing a drug-
free animal to the drug-associated context multiple times, so that new learning overrides 
the drug-context association. After extinction training, an animal no longer spends more 
time in the morphine than in the saline context (Tzschentke, 2007). Just as CPP models 
trigger formation, CPP extinction models cue exposure therapy. In this clinical treatment, 
drug-related cues are repeatedly presented to an addicted patient in order to reduce drug-
stimulus associations and the accompanying drug craving that makes addicts vulnerable to 
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relapse (Kantak & Nic Dhonnchadha, 2011; Vollstadt-Klein, et al., 2011). Cue exposure 
therapy, combined with biofeedback and relaxation techniques during the cue exposure 
period, dramatically reduces cue-elicited heroin craving in abstinent addicts (Du, et al., 
2014). 
Opioids have abuse potential because they activate the mesocorticolimbic reward 
system. Opioids induce reward by binding the μ opioid receptor on ventral tegmental area 
(VTA) interneurons, thus disinhibiting VTA dopaminergic neurons and causing them to 
release dopamine into the nucleus accumbens (NAc) (Johnson & North, 1992). This 
dopamine release marks the associated environment (surrounding cues and contexts) as 
salient, triggering learned associations between the motivational event and co-occurring 
environmental stimuli as occurs in morphine CPP acquisition (Pecina & Berridge, 2013; 
Kalivas & Volkow, 2005). Accordingly, antagonists of the D1 and D2 dopamine receptors 
prevent acquisition of morphine CPP when administered before morphine injections 
(Acquas et al. 1989; Fenu et al., 2006). Also, D1 and D2 receptor knockout mice do not 
acquire morphine CPP (Wang, et al., 2015; Maldonado, et al., 1997). Agonists of the D1 
dopamine receptor (D1R) enhance, while agonists of the D2 dopamine receptor (D2R) 
attenuate low-dose heroin self-administration (Rowlett et al., 2007). After pairing of drug 
intake with external stimuli, dopamine release will occur not only in response to a drug 
exposure, but to a drug-associated cue by itself, so that dopamine probably plays a role in 
maintaining CPP (Kalivas & Volkow, 2005). In fact, dopamine levels in the NAc decrease 
with extinction of reward-cue associations, and increase again upon reinstatement (Ranaldi 
et al., 1999; Sunsay et al., 2014). The effect of dopamine receptor agonists or antagonists 
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specifically on morphine CPP extinction has not been studied previously. Reinstatement 
studies show that blockade of the D1R in the NAc and hippocampus, and blockade of the 
D2R in the hippocampus, decreases reinstatement of morphine CPP induced by a priming 
dose of morphine (Khakpour-Taleghani et al., 2015; Sadeghzadeh et al., 2015). In 
summary, both D1Rs and D2Rs are necessary for morphine reward, but D1R activation 
appears to consistently enhance reward, while the D2R has more complicated effects.  
Changes in NAc neuron morphology may be a part of how the brain encodes 
morphine CPP. The neurons of the NAc are called medium spiny neurons (MSNs) because 
of their distinct morphology: numerous dendrites with dense spine distributions that hold 
many excitatory synapses (Pierce & Wolf, 2013). Because morphological properties such 
as dendritic tree complexity mediate the electrotonic properties of neurons, morphology 
can impact the way post-synaptic potentials are integrated to induce action potential firing 
(Segev, 2006; Carter et al., 2007; Mainen & Sejnowski, 1996). In other words, morphology 
can determine how an MSN will react to input information, and therefore, how information 
is propagated between neurons. Seminal work has shown that withdrawal from self-
administered or experimenter-administered morphine is associated with decreased spine 
density and dendritic complexity of neurons in the NAc (Robinson & Kolb, 1999; 
Robinson et al., 2002). In a recent study, we found that morphine CPP is correlated with 
increased dendritic length and complexity of neurons in the NAc core (Kobrin et al., 2015). 
We also found that extinction of morphine CPP is associated with decreased complexity of 
neurons in the NAc core (Leite-Morris et al., 2014). The dopamine neurotransmission that 
mediates morphine CPP behavior may also mediate morphine CPP-induced increases in 
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dendritic complexity. Dopaminergic neuron co-culture and D1R and D2R agonists increase 
dendritic complexity and spine density of MSNs in vitro, and D1R agonists increase 
dendritic complexity and spine density of cortical neurons in vivo (Fasano et al., 2013; Li, 
et al., 2014). Whereas dopamine depletion decreases spine density and dendritic length of 
MSNs in the NAc (Meredith et al., 1995).  
We hypothesize that dopamine mediates the increased dendritic complexity of 
MSNs that is correlated with morphine CPP. This hypothesis is based on the fact that 
dopamine mediates the formation of drug-cue associations and independently increases 
dendritic complexity and spine density of neurons. If this hypothesis is correct, dopamine 
should maintain CPP in the face of extinction training, and it should maintain the 
underlying increased dendritic complexity of NAc core MSNs. To test this idea, we chose 
to study the effect of a D1R agonist on morphine CPP extinction and associated structural 
plasticity in the NAc. We chose the D1R because this receptor has been clearly and 
consistently associated with morphine reward, while the role of the D2R is more 
complicated. Since extinction of morphine CPP is associated with lower dendritic 
complexity than retention of CPP, and D1 activation is associated with increased dendritic 
complexity, we hypothesized that D1R activation would impede extinction because it 
would increase dendritic complexity.  We used an optimally effective morphine dose (10 
mg/kg s.c.) to induce CPP in mice, or s.c. saline as a control, and then tested them for place 
preference in a CPP device (Leite-Morris et al. 2014).  After CPP expression was 
confirmed, mice underwent extinction training. Groups of mice were treated with different 
doses of D1 agonist during extinction, while controls were treated with saline. After 
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extinction training, brain samples were processed using Golgi-Cox staining to identify 
single MSNs in the NAc core and shell. We analyzed morphology by comparing dendritic 
complexity and spine density measures between groups.  
 
4.2 Materials and Methods 
 4.2.1 Animals 
 Male C57BL/6 mice from Charles River Laboratories (Raleigh, SC) were used 
because they display measurable indications of reward, stimulation, and sensitization in 
response to morphine (Leite-Morris et al. 2004; Heinrichs et al. 2010). Mice were 
acclimated to a 12 hour light/dark cycle for at least 7 days before the study. Animal testing 
was performed in a facility approved by the Association for the Assessment and 
Accreditation of Laboratory Animal Care and approved by the Institutional Animal Care 
and Use Committee of the VA Boston Healthcare System. The experiments were carried 
out in accordance with the Guide for the Care and Use of Laboratory Animals as adopted 
and promulgated by the National Institutes of Health. A total of 141 were used for 
behavioral studies, and a subset of these mice were used for neuron morphology studies. 
 4.2.2 Drug Administration 
 A subcutaneous (s.c.) 10 mg/kg dose of morphine was administered to mice to 
induce CPP. Morphine dose, administration route, and time of administration were selected 
based on past experience with CPP (Heinrichs et al. 2010; Leite-Morris et al. 2014). 
Dopamine D1R agonist SKF81297 was administered subcutaneously (s.c.) at doses of 0.5 
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mg/kg and 0.8 mg/kg after extinction sessions, as these doses were shown to alter learning 
and memory and to be below the threshold to produce seizures in mice (Izquierdo, et al., 
2006; Gangarossa, et al., 2011).  
 4.2.3 Morphine Place Conditioning 
Mice were trained to acquire CPP in an apparatus (Mouse Place Preference; Med 
Associates, St. Albans, VT) consisting of a middle chamber (7.25 x 12.70 cm) with 
automatic guillotine doors situated in between two black conditioning chambers of equal 
size (16.75 x 12.70 cm). The conditioning chambers to the left and right of the middle 
chamber were identical except for floor texture (mesh vs bar) (Leite-Morris et al. 2014). 
Interruption of infrared beams inside the chambers tracked movement of animals over time, 
and was used to calculate the total time a mouse spent in each chamber. A graphical 
summary of behavioral procedures is presented in Figure 24. 
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Figure 24: Diagram of morphine CPP acquisition and extinction behavioral procedures. 
For preference testing on day 1, mice were placed in the center compartment of the 3 
chambered conditioning apparatus and allowed free access to all compartments for 15 min. 
Time spent in the left and right chambers (mesh vs. bar flooring) was recorded by infrared 
beam breaks, and mice that spent more than 66% of the time in one chamber were not used 
in the study. Preference score was calculated by subtracting the time spent in the saline-
paired from the time spent in the drug-paired chamber. CPP acquisition occurred on days 
2-9. Mice were injected with 10 mg/kg morphine immediately before a 50 minute 
confinement to the assigned drug-paired chamber, and on alternate days were injected with 
saline before confinement to the assigned saline-paired chamber. A control group was 
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confined to the two different chambers on alternate days, but was injected with saline every 
day. On day 10, mice were tested for preference using a procedure identical to that used on 
day 1. Extinction occurred on days 11-19 and consisted of 50 minute confinements to the 
drug-paired or saline-paired chambers on alternate days. Immediately after each 50 minute 
confinement, morphine-conditioned mice were injected with saline, 0.5 mg/kg SKF81297, 
or 0.8 mg/kg SKF81297, while saline-conditioned mice were only injected with saline 
(days 11-12, 14-15, and 17-18). Preference testing occurred every third day during 
extinction (days 13, 16, and 19) to observe the effect of extinction training over time. Mice 
were sacrificed, and brains were removed for Golgi-Cox staining on day 20. 
 
CPP training was preceded by a pre-conditioning preference test on day 1. Mice were 
acclimated in the middle chamber for 30 seconds. Then, doors opened automatically and 
mice were allowed 15 minutes of free access to all chambers. Total time spent in each of 
the conditioning chambers was recorded. Because our design is unbiased, mice that 
exhibited an unconditioned place preference, or spent more than 67% of the total time in 
one chamber, were labelled biased and were excluded from the study.  
During conditioning, morphine (10 mg/kg) and saline were subcutaneously (s.c.) 
administered on alternating days to morphine-conditioned mice. Immediately after 
injection of saline or morphine, mice were placed in the assigned conditioning chamber for 
50 minutes (Days 2-9). For balanced conditioning, half of the morphine-conditioned mice 
associated morphine with the left, and half with the right, conditioning chamber. The 
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chamber not assigned to morphine served as an internal control, and was associated with 
saline treatment. Saline-conditioned mice received saline s.c. every day, and were placed 
in left or right conditioning chambers on alternating days (Heinrichs et al., 2010).  
The post-conditioning test, identical to the pre-conditioning test, occurred on the day 
after the final conditioning session (day 10). “Preference score” was defined as time spent 
in the morphine-paired chamber minus time spent in the saline-paired chamber.  
All mice underwent three extinction training sessions, Extinction I (days 11-12), 
Extinction II (days 14-15), and Extinction III (days 17-18).  During extinction training, 
drug-free mice were confined to left or right conditioning chambers for 50 minutes on 
alternating days. The morphine-conditioned group was broken down into three subgroups 
that received an injection of either saline, 0.5 mg/kg SKF81297, or 0.8 mg/kg SKF81297 
after each 50 minute period of confinement to either chamber on days 11, 12, 14, 15, 17, 
and 18. Saline-conditioned control mice received saline after confinement to either 
chamber. Drug was given after confinement to a chamber because a previous study of 
cocaine CPP extinction found changes in extinction when a different D1R drug was 
administered after extinction sessions (Fricks-Gleason et al., 2012). The purpose of active 
extinction training in morphine conditioned mice was to diminish the predictive value of 
tactile and contextual cues associated with conditioned place preference relative to the 
baseline established by morphine naïve (saline) controls in which a place preference was 
never conditioned.  Mice underwent post-extinction training preference tests after each pair 
of left and right chamber exposures on days 13, 16, and 19, and preference score was 
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calculated at each time-point. Mice were euthanized for Golgi-Cox staining on day 19, one 
day after the last post-extinction preference test. 
4.2.4 Dendritic Morphology Procedures 
 Brains were removed and stained using the FD Rapid GolgiStainTM Kit (FD 
NeuroTechnologies, Inc., Catonsville, MD). After Golgi stain immersion, whole brains 
were snap-frozen in 2-methylbutane, encased in Tissue Freezing Medium (Triangle 
Biomedical Sciences, In., Durham, NC, USA), sectioned at 100 µm on a cryostat 
microtome (Leica Microsystems Inc., Buffalo Grove, IL), and mounted on chrome alum 
gelatin coated slides. Sections then underwent the rest of the Golgi stain process using the 
directions from the GolgiStainTM Kit. 
 Sections containing the NAc were visualized with an Olympus BX51 bright field 
microscope interfaced with a color digital camera (MicroFire Optronics, Goleta, CA). 
Groups of MSNs from two brain regions, the NAc shell and core, were traced. All neurons 
were traced within the NAc between rostral/caudal coordinates +1.54 to +0.98 mm relative 
to bregma. Neurons for NAc core tracings had cell bodies located within 150 µm from the 
edges of the anterior commissure. Neurons for NAc shell tracings had cell bodies located 
500-1000 µm from the medial or ventrolateral edges of the anterior commissure (Franklin 
& Paxinos 2007). In order to be classified as MSNs and traced, neurons had to have visible 
and distinct individual dendrites and a number of dendrites had to have dense regions of 
spines. Cells with distinct individual dendrites, but without many spines were presumed to 
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be interneurons and were not traced (Tepper et al. 2010). Cells with numerous projections 
in a radial distribution were classified as astrocytes, and were not traced.  
 All dendrites on 3-5 individual MSNs per brain region in each mouse were 
manually traced at 60X using Neurolucida software (MBF Bioscience, Williston, VT). To 
estimate spine density on each MSN, dendritic spines were traced on all dendritic segments 
present between 30-60 μm from the soma’s center (Brown & Kolb 2001; Juarez et al. 
2011). The software analyzed each MSN tracing for spine density, dendritic length, 
dendritic count, and Sholl analysis in order to quantify morphology. Spine density was 
defined as the number of spines divided by the length of the dendrite upon which all of 
those spines reside, multiplied by 10, in units of number of spines/10 μm dendrite. 
Dendritic length was defined as the sum of the length of all dendrites on an MSN, in units 
of μm. Dendritic count was defined as the sum of the number of all dendritic branches (1st, 
2nd, 3rd, 4th order, etc.) on an MSN. In the Sholl analysis, equidistant (10 µm) concentric 
circles are superimposed on the neuron tracing, and centered on the soma. The number of 
times each circle is crossed by a dendrite is tabulated as the number of intersections at each 
radius (Figure 25) and is a measure of dendritic arbor complexity (Binley et al. 2014). 
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Figure 25: Representative nucleus accumbens medium spiny neuron and its digital tracing. 
(A) 40X photomicrograph of a medium spiny neuron (MSN) in the nucleus accumbens 
(NAc) stained with the Golgi-Cox method. White scale bar is 20 μm long. (B) Digital 
tracing of the same NAc MSN. Primary (1⁰) dendrites attach directly to the soma. 
Secondary (2⁰) dendrites branch from primary dendrite bifurcations. Tertiary (3⁰) dendrites 
branch from secondary dendrite bifurcations. Quaternary (4⁰) dendrites branch from 
tertiary dendrites. Quinary (5⁰) dendrites branch from quaternary dendrites. (B) To 
examine dendritic complexity, a grid of concentric circles of increasing radii is 
superimposed on a neuron’s digital tracing for Sholl analysis. The number of dendritic 
intersections is defined as the number of times each circle is contacted by a dendritic 
branch.  
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 4.2.5 Statistical Analysis  
 Data were analyzed using GraphPad Prism 6.0 (GraphPad, La Jolla, CA, USA). 
Significance for all analyses was set at the p<0.05 level.  Using the ROUT test to detect 
outliers in behavioral data, only one mouse was excluded from data analysis. Behavioral 
data were examined using two-way repeated measures ANOVA, with factors of time and 
treatment group, followed by a post-hoc Tukey’s multiple comparisons test to compare 
between and within treatment groups at each level of the experimental phase. Data for each 
morphology measure from 3-5 neurons per mouse were averaged to create individual 
values for each mouse that were then averaged together to create mean values for each 
group in each brain region. Dendritic parameters, including total dendritic length, total 
dendritic count, and spine density, were examined using unpaired t-tests. Sholl analysis 
was evaluated using two-way repeated measures ANOVA, with factors of radius and 
treatment group, followed by post-hoc Tukey’s to compare the number of intersections at 
each radius level. 
 
4.3 Results 
 4.3.1 D1 receptor agonist impedes extinction of morphine conditioned place 
preference  
 Mice underwent morphine conditioning followed by extinction trials. After each 
extinction training session, one group was injected with saline s.c. (morphine-
conditioned/saline), one group was injected with dopamine D1 receptor agonist SKF81297 
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0.5 mg/kg s.c. (morphine-conditioned/0.5 SKF), and a third group was injected with 
SKF81297 0.8 mg/kg s.c. (morphine-conditioned/0.8 SKF). A control group was injected 
with only saline s.c. during conditioning and extinction (saline-conditioned/saline).  
Preference testing occurred five times during the study: pre-conditioning, post-
conditioning, and after extinction sessions I, II, and III (Figure 26).  Two-way repeated 
measures ANOVA revealed a significant interaction of treatment and time [F(12,548) =3.8, 
p<0.0001], and significant main effects of both time [F(4,548) =36.9, p<0.0001] and drug 
treatment [F(3, 137) =18.7, p<0.0001] on preference scores.   
 Post-hoc between group Tukey’s analysis revealed that at the post-conditioning 
phase (Post-Test), all morphine-conditioned groups exhibited significantly higher 
preference scores than the saline-conditioned group (p<0.0001).  Thus, these three groups 
demonstrated expression of morphine place preference. This morphine CPP was then 
diminished over three extinction sessions. Post-hoc between group Tukey’s analysis 
revealed that after two days of extinction training (Post-Ext I), morphine-
conditioned/saline (p<0.0001), morphine-conditioned/0.5 SKF (p<0.0001), and morphine-
conditioned/0.8 SKF (p<0.0001) mice had not extinguished, rather, they retained place 
preference in comparison to saline-conditioned mice. Morphine-conditioned/saline 
(p<0.001), morphine-conditioned/0.05 SKF (p<0.05), and morphine-conditioned/0.8 SKF 
(p<0.0001) mice were still not extinguished after four days of extinction training (Post-Ext 
II), as compared to saline-conditioned mice. After all 6 days of extinction training (Post-
Ext III), the morphine-conditioned/saline and morphine-conditioned/0.5 SKF groups had 
extinguished, as their mean preference scores were not significantly different from that of 
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the saline-conditioned group. The morphine-conditioned/0.8 SKF (p<0.0001) group did 
not extinguish by Ext III, as they had significantly higher preference scores than the saline-
conditioned (p<0.0001) and morphine-conditioned/saline (p<0.05) groups.  
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Figure 26: The D1 agonist SKF81297 (0.8 mg/kg) impedes extinction. Mice acquired 
morphine CPP and then during extinction were injected with saline (M/Sal), 0.5 mg/kg 
SKF81297 (M/0.5 SKF), or 0.8 SKF81297 (M/0.8 SKF) after each exposure to the drug-
paired or saline-paired chambers. Controls were conditioned with saline and injected with 
saline during extinction (Sal/Sal). All morphine-conditioned mice expressed robust CPP. 
By the third set of exposures to the drug-paired and saline-paired chambers, the morphine-
conditioned groups injected with saline and 0.5 mg/kg SKF81297 during extinction no 
longer expressed place preference, while injection with 0.8 mg/kg SKF81297 impeded 
extinction of place preference. ****p<0.0001 as compared to the Sal/Sal group, 
***p<0.001 as compared to the Sal/Sal group, *p<0.05 as compared to the Sal/Sal group, 
and #p<0.05 indicates a difference between the M/Sal and M/0.8 SKF groups. 
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 4.3.2 Effects of D1 agonist on dendritic complexity of neurons in the NAc core and 
shell 
 Because the D1 agonist treatment created a significant difference in place 
preference between the morphine-conditioned/0.8 SKF and the morphine-
conditioned/saline groups, the morphology of neurons in the NAc core and shell was 
quantified in these two groups. We stained brains using the Golgi-Cox method, then made 
digital tracings of individual neurons in each brain region. We assessed dendritic 
complexity by measuring the mean total dendritic length, mean total dendritic count, and 
mean Sholl dendritic intersections of NAc core and shell MSNs. Unpaired t-testing showed 
no significant difference in dendritic count (number of dendritic branches) between the 
morphine-conditioned/0.8 SKF and the morphine-conditioned/saline groups in the core or 
shell (Figure 27A and 28A).  
Unpaired t-testing showed a significant difference in dendritic length between the 
morphine-conditioned/0.8 SKF and the morphine-conditioned/saline groups [t=2.522, 
df=8, p<0.05] in the NAc core, but not in the shell. NAc core MSNs of the morphine-
conditioned/0.8 SKF group had 23% longer total dendritic length than those of the 
morphine-conditioned/saline group (Figure 27B and 28B). 
A Sholl analysis tabulates the number of intersections that dendrites make with each 
circle in a grid of concentric circles superimposed on an MSN tracing. Two-way repeated 
measures ANOVA showed that there was no interaction effect, a main effect of circle 
radius [F (11, 88) = 87.94, p<0.0001], and a main effect of treatment [F (1, 8) = 7.036, 
p<0.05] on number of intersections in the NAc core, but no effects in the shell (Figure 27D 
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and 28D).. Post-hoc testing revealed that the morphine-conditioned/0.8 SKF group 
demonstrated more intersections in the NAc core than the morphine-conditioned/saline 
group at the 70 µm (p<0.01) radius. For a representative photo summary of neurons from 
both treatment groups in the core and shell, see Figures 29 and 30. 
 4.3.3 Effects of D1 agonist on spine density of neurons in the NAc core and shell  
We tabulated spine density (number of spines per 10 µm of dendrite) by counting 
spines on dendritic segments between 30-60 μm from the soma (Brown & Kolb 2001; 
Juarez et al. 2011). An unpaired t-test showed a significant difference between the spine 
density of morphine-conditioned/0.8 SKF and morphine-conditioned/saline groups in the 
NAc core [t=3.349, df=8, p<0.05], but not in the shell (Figure 27C and 28C). NAc core 
MSNs of the morphine-conditioned/0.8 SKF group had 24% higher spine density than 
those of the morphine-conditioned/saline group.  
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Figure 27: D1 agonist is associated with increased dendritic complexity and spine density 
in the NAc core. Saline or D1 agonist SKF81297 0.8 mg/kg s.c. was administered to 
morphine-conditioned mice after each 50 minute exposure to the drug-paired and saline-
paired chambers during extinction training. Treatment with 0.8 mg/kg SKF81297 
compared to treatment with saline was associated with no difference in number of dendrites 
(A), longer total dendritic length (B), higher spine density (C), and more complex 
arborization as measured by increased intersections using the Sholl analysis (D). *p<0.05 
indicates a difference between the Morphine/saline and Morphine/0.8 SKF groups. 
**p<0.01 indicates a difference between the Morphine/saline and Morphine/0.8 SKF 
groups at the 70 𝜇m radius. 
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Figure 28: D1 agonist is not associated with changes in dendritic complexity or spine 
density in the NAc shell. Saline or D1 agonist SKF81297 0.8 mg/kg s.c. was administered 
to morphine-conditioned mice after each 50 minute exposure to the drug-paired and saline-
paired chambers during extinction training. Treatment with 0.8 mg/kg SKF81297 
compared to treatment with saline was associated with no difference in number of dendrites 
(A), total dendritic length (B), spine density (C), or arborization as measured by 
intersections using the Sholl analysis (D).  
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Figure 29: Representative Photos and Tracings of NAc Core Neurons. Neurons are shown 
from the two treatment groups that received morphine conditioning, and either (A) saline 
or (B) 0.8 mg/kg SKF81297 during extinction training. Scale bar in red is 10 μm. Insets 
show representative dendritic spine density on single dendrites at 60X.  
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Figure 30: Representative Photos and Tracings of NAc Shell Neurons. Neurons are shown 
from the two treatment groups that received morphine conditioning, and either (A) saline 
or (B) 0.8 mg/kg SKF81297 during extinction training. Scale bar in red is 10 μm. Insets 
show representative dendritic spine density on single dendrites at 60X.  
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4.4 Discussion 
 We sought to determine the effect of parenteral dopamine D1 receptor agonist 
administration on extinction of morphine CPP, and on associated dendritic complexity in 
the NAc. We found a dose-dependent effect of D1 agonist SKF81297 on extinction of 
morphine CPP, with a significant effect of the 0.8 mg/kg dose and no effect of the 0.5 
mg/kg dose. The 0.8 mg/kg dose of SKF81297 impeded extinction, as the preference scores 
of mice treated with it were significantly higher than those of controls. MSNs from the 
NAc core of mice in the morphine-conditioned/0.8 SKF group had more complex dendritic 
arbors and higher spine density than those from the morphine-conditioned/saline group.  
 A critical role for D1 receptors in drug reward and conditioning has been 
established in the literature. Morphine CPP expression is correlated with expression of 
surface membrane D1R in NAc neurons and blockade of this receptor inhibits the 
acquisition of morphine CPP (Sun et al., 2013; Acquas et al. 1994; Liu et al., 2003). 
Activation of D1 receptors through administration of D1 agonists can produce a place 
preference (Graham et al., 2006). In the current study, we ruled out the possibility of 
SKF81297 creating its own place preference because it was never administered before 
exposure to the CPP chambers, and because it was administered after exposure to both of 
the chambers, not only after exposure to the morphine-associated chamber.    
 The effect of direct activation or blockade of D1 receptors on morphine CPP 
extinction has not previously been studied, but it has been studied in cocaine conditioned 
reward. A partial agonist of D1 receptors, SKF38393, facilitated extinction of cocaine CPP 
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when injected into the prelimbic PFC prior to extinction training sessions (Brenhouse et 
al., 2010), while systemic D1R antagonist SCH39166 (ecopipam) impaired extinction of 
cocaine CPP when given after extinction training sessions (Fricks-Gleason, et al., 2012). 
This finding highlights the importance of timing, so that activating the D1 receptor during 
or before extinction training may have different effects than activation after training. Since 
post-extinction session D1R antagonist blocked cocaine CPP extinction, and in our study 
post-extinction session D1R agonist impeded morphine CPP extinction, it may be that a 
certain level of D1R function is necessary for the consolidation of extinction memory. In 
fact, work has shown that very high doses of D1R agonist SKF81297 can induce memory 
deficits in learning paradigms unrelated to addiction (Zahrt et al., 1997). Possibly, an 
intermediate response of the D1R receptor enhances memory, while too much activation 
or inhibition impedes it.  
 An alternative explanation is that a D1R agonist may prevent extinction from 
completely forming by activating the dopamine salience mechanism, and marking the CPP 
chamber as still salient. During extinction of pavlovian conditioning with food, NAc 
dopamine levels slowly fall throughout extinction sessions (Sunsay et al., 2014). Since we 
injected mice with a D1R agonist immediately after extinction sessions, the increased 
dopamine receptor activation may have counteracted the slow decline in dopamine that 
may have been occurring throughout the session, and extinction learning may therefore not 
have been completed normally.  
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 In our previous work, we did not find that morphine CPP extinction altered spine 
density on NAc core neurons as compared to CPP maintenance (Leite-Morris et al., 2014). 
The current study differs in that SKF8197-induced maintenance of morphine CPP was 
associated with increased spine density when compared to extinction of morphine CPP. It 
is expected that a D1R agonist would increase spine density, because this has been shown 
to happen in vitro (Fasano, et al., 2013). Since it was not measured in an identical manner 
throughout all studies, spine density findings from this study cannot be compared well with 
spine density findings from our previous studies. 
 In the current study, we calculated spine density only at the proximal sections of 
dendrite, between 30-60 μm from the soma. Many dopaminergic synapses are found on 
dendrites proximal to the soma (Quirk & Mueller, 2008). Spine density changes in the 
morphine-conditioned/0.8 SKF mice group may have affected areas of the dendritic tree 
that are most relevant for functional communication in the dopaminergic reward pathway. 
If the increased spine density included generation of many dopaminergic synapses, then 
the MSNs of SKF81297 treated mice may have been more reactive to dopamine than the 
MSNs of morphine-conditioned/saline mice. A lower level of dopamine release may have 
been able to reinforce reward associations in the SKF81207 treated mice, maintaining place 
preference in the absence of the dopamine release associated with morphine. Conversely, 
in the control mice, density of dopaminergic spines may have been at a lower level that 
would only respond to the larger dopamine bursts that accompany morphine intake, thus 
the association of a chamber with reward was not maintained in the absence of morphine. 
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 In previous work, our group found that morphine CPP acquisition is associated with 
increased, and that extinction is associated with decreased NAc core dendritic complexity 
(Kobrin et al., 2015; Leite-Morris et al., 2014). The findings in this study mirror our 
previous findings in that after extinction, mice that still expressed CPP (the morphine-
conditioned/0.8 SKF mice) had NAc core neurons with higher dendritic complexity than 
mice whose CPP was successfully extinguished (morphine-conditioned/saline mice). Since 
SKF81297 increases dendritic complexity in vitro, the dendritic complexity effect may be 
due to D1 agonist administration (Li, et al., 2014).  
 In the current study, it appears that the D1R agonist may inhibit CPP extinction by 
maintaining the increased dendritic complexity associated with morphine CPP acquisition 
and by preventing the reductions in dendritic complexity that are associated with extinction 
(Kobrin et al., 2015; Leite-Morris et al., 2014). These changes in neuron morphology have 
an effect on the electrotonic properties of neurons, and may drive changes in neuron 
activity (Stiefel & Sejnowski, 2007). Elaboration of the dendritic tree after morphine CPP 
may decrease overall excitability by increasing capacitance and thus low-pass filtering 
(Shepherd, 2008). We theorize that increased dendritic complexity leads to decreased 
overall excitability so that a NAc core neuron will respond more selectively, in this case, 
to the morphine associated, salient, environment to drive CPP behavior. As a counterpart, 
we hypothesize that the reduction in dendritic complexity associated with extinction makes 
NAc core neurons more generally excitable (Shepherd, 2008), and makes them less 
selectively reactive to specific stimuli that were previously salient, such as the morphine-
associated chamber. Without selectivity of response, the NAc core neurons no longer 
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differentiate the neutral and morphine-associated chambers, and therefore CPP can no 
longer be expressed.    
A possible explanation for why our findings were in the NAc core is that this region 
has a role of translating multiple streams of information into motivated motor behavior (Ito 
and Hayen, 2011). The system that is theorized to be responsible for generating drug 
seeking behavior in response to drug-associated stimuli is the VTA-BLA-PFC-NAc core-
VP circuit (Kalivas & Volkow, 2005). Dopamine released during drug-cue associative 
learning may strengthen the connections between the PFC and NAc core drug seeking 
pathway. The PFC uses glutamate to signal to the NAc core, and dopamine can upregulate 
subunits of glutamate receptors in the post-synaptic membrane, enhancing synaptic 
signaling (Smith et al., 2005). Since the dopamine receptors of morphine-conditioned/0.8 
SKF mice were being activated, there could have been upregulation of glutamate receptors 
in the post-synaptic membrane. SKF81297 may have inhibited extinction and maintained 
place preference by strengthening PFC to NAc core glutamatergic signaling, thereby 
reinforcing the drug seeking pathway.   
 It has been thought that extinction is new learning, associated with strengthening 
of a new pathway in the brain that inhibits the pathway induced by learning of the original 
behavior (Bouton, 2004). This was hypothesized because extinguished behavior can 
spontaneously return. This may still be true, but our studies shows that CPP extinction can 
reverse increases in dendritic complexity induced by acquisition. In addition to new 
learning, extinction may also encompasses some alteration of the original learning. 
Research in conditioned fear extinction has demonstrated reversal of some of the 
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morphology changes originally induced by conditioned fear acquisition (Vetere, et al., 
2011). As a hypothesis, if extinction reverses some of the brain changes that were originally 
induced by learning a certain behavior, it may alter the pathway induced by the original 
behavior. This altered pathway may not respond as readily as the original pathway, but the 
behavior could still reactivate in certain circumstances, such as with a prime or during 
stress or in a different context.  Indeed, computational models of extinction of conditioned 
eyeblink suggest that extinction reverses some, but not all changes induced by conditioned 
learning, and the authors caution against the idea of categorizing extinction in general as 
either completely new learning or strict unlearning (Mauk & Ohyama, 2004). 
 The results of this study warrant further research to clarify and interpret the 
conclusions. In a translational approach, this study used a systemic administration of 
SKF81297 in two different doses with extinction training to simulate a clinical situation in 
which a systemic drug may be given in conjunction with exposure therapy. In order to 
determine if the behavioral effects of D1R agonism are specific to certain brain regions, 
such as the NAc core where we found an effect on neuron morphology, this study should 
be repeated using intra-cranial injections. Our study used an injection time point 
immediately after each extinction session. This study therefore may be targeting memory 
consolidation, but it does not look at the effects of SKF81297 at different time points after 
extinction, to target longer-term consolidation processes. It also does not look at what 
happens when SKF81297 is administered before extinction sessions, to target initial 
extinction formation. Also, this study should be repeated with more doses of SKF81297 to 
confirm the dose-response effect in the domains of both behavioral and morphology 
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responses. Also, repeating this study with another method of quantifying morphology, 
especially a three dimensional visualization method, since Golgi-Cox is only two 
dimensional, would be helpful to confirm the current results. To explore the idea of 
extinction as a combination of new learning and reversal of previous learning, future 
studies should examine other brain regions to determine if they undergo an extinction 
induced reversal of CPP acquisition-associated changes. 
 In conclusion, we found a dose-dependent effect of SKF81297 given after every 
extinction training session such that the highest dose impeded extinction and promoted 
maintenance of morphine CPP, a state which was associated with increased dendritic 
complexity and spine density in the NAc core in this study. These results indicate that 
activation of D1 receptors prevent extinction and may be critical for maintenance of 
conditioned reward or blockade of extinction consolidation, possibly by maintaining 
increased dendritic complexity and spine density in the NAc core. Since extinction seems 
to reverse CPP acquisition-induced increases in dendritic complexity, extinction may be a 
process of new learning in combination with some reversal of previous learning.  
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Chapter 5: Discussion 
 Opioid abuse is detrimental to an individual’s health, relationships, and to society 
as a whole. One of the most difficult aspects of treating addiction is for the patient to 
maintain abstinence. The main impediment to preventing relapse is drug craving, which 
can be potentiated by exposure to stimuli that have become associated with opioid use, 
known as triggers (Mayet et al., 2005). Cue-exposure therapy is a part of drug addiction 
treatment that uses repeated exposure to triggers in the absence of drug to extinguish the 
triggers’ association with drugs of abuse, and therefore, to reduce a trigger’s ability to 
promote relapse (Du, et al., 2014). We used conditioned place preference (CPP) as an 
animal model of trigger formation, and CPP extinction as a model of exposure therapy, to 
characterize the brain substrates underlying acquisition and extinction of drug-related 
associations. Eventually, these brain substrates may become targets for treatments that aim 
to abolish triggers and aid in relapse prevention.  
 The NAc is a key brain substrate in opioid abuse and trigger formation. It is a central 
brain region in the mesocorticolimbic reward system that is thought to detect reward by 
receiving bursts of dopamine from the ventral tegmental area (Di Chiara, 1999). More 
recently, it has been hypothesized to direct behavior based on its integration of reward with 
other information (Chartoff & Connery, 2014). Both the core and shell subregions of the 
NAc mediate aspects of opioid reward and CPP. The delineation of these subregions is 
based on different connectivity, different responses to stimuli, and differential functions 
(Sesack and Grace, 2010; Everitt and Robbins, 2005).  
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 Although opioid CPP-related changes in electrophysiology, neurotransmitter 
signaling, genetics, and protein makeup of the NAc have been examined, changes in NAc 
neuron morphology accompanying opioid CPP have not been studied previously. Signaling 
between neurons and their connectivity to one another depends in part on their morphology, 
that is, the arrangement of their dendrites, axons, and spines. Neurons receive 
neurotransmission at their dendrites and dendritic spines, which house the synapses where 
axons terminate. Signal conduction along dendrites depends on their morphology, 
specifically length and girth (Koester & Siegelbaum). Dendrites conduct signals from 
synapses towards the cell body of a neuron, where signals must integrate to determine the 
output of the neuron. Therefore, changes in dendritic structure have an effect on “intrinsic 
spontaneous action potential generating capacity” of neurons (Diana 2011). Also, research 
in multiple types of learning paradigms have found evidence that morphology changes may 
mediate learning. It is known that opioid administration alters neuron morphology, but the 
effect of opioid CPP, a combination of opioid and learning effects, on morphology has not 
been established in the literature. Because of its importance to neuron connectivity and 
relevance to learning paradigms, we sought to characterize the structural complexity of 
neurons in the NAc after morphine CPP acquisition and extinction.  
 Past work has characterized the effects of many drugs of abuse on morphology of 
neurons in the NAc. Stimulant drugs of abuse have been shown to increase spine density 
and dendritic complexity in the NAc shell and core, while ethanol has been shown to reduce 
spine density (Robinson & Kolb 2004; Zhou et al. 2007).  Self-administration of morphine 
is associated with increased dendritic complexity and spine density in the prelimbic cortex, 
131 
 
but decreased dendritic complexity in the frontal cortex (Ballesteros-Yanez et al., 2007). 
Experimenter-administered morphine, followed by withdrawal, is associated with 
decreased dendritic complexity and spine density in the NAc shell, while self-
administration is associated with even more dramatic reductions in NAc shell structural 
complexity, possibly because contingent learning takes place in the latter (Robinson & 
Kolb, 1999; Robinson et al, 2002; Russo et al., 2010).  
 Our morphine CPP acquisition protocol used 4 injections of morphine every other 
day, with the morphine homecage controls receiving the same regimen. We found the 
saline-conditioning has no effect on morphology of NAc core MSNs, so comparison of 
data from this group to data from the morphine homecage group may be used to isolate the 
drug effect of the morphine regimen alone on morphology. In this comparison, we found 
that morphine administration leads to increased spine density in the NAc core, which adds 
to previous findings that morphine followed by withdrawal causes decreased spine density 
in the NAc shell. We found no significant effect of morphine in the shell, although the 
morphine homecage group did have lower mean spine density than the saline-conditioned 
group. Previous studies used large daily doses of morphine for weeks, while we used only 
4 smaller doses on alternate days. If we had used a large chronic dose regimen for morphine 
administration, it is possible that our NAc shell results would have become significant, and 
would have matched other studies showing reduced NAc shell spine density after morphine 
administration. We did not have a morphine homecage group in the extinction trial, but it 
would be interesting to know if a longer withdrawal period, as happens during extinction, 
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would result in a statistically significant reduction of NAc shell medium spiny neuron 
(MSN) spine density. 
 In this work, we found that acquisition of morphine CPP is associated with 
increased dendritic complexity of MSNs in the NAc core, and that extinction of morphine 
CPP is associated with reduction of dendritic complexity in the NAc core. Specifically, 
morphine-conditioned mice had increased dendritic complexity as compared to two control 
groups. The first control group was trained with CPP procedures, but only got saline 
injections, so did not actually acquire conditioned learning because no drug effects were 
experienced. The second control group was never behaviorally trained, but did receive 
morphine injections in the homecage, and so did experience drug effects, but did not 
experience context-based learning. Since morphine-conditioned mice had higher dendritic 
complexity than either control group, it is apparent that the increased complexity is a 
unique effect of the combination of drug and learning, and is different from the effects of 
the drug or CPP procedure by themselves. In the extinction experiment, mice that 
extinguished CPP had lower dendritic complexity than unextinguished control mice that 
retained CPP. On most measures, dendritic complexity of extinguished mice did not differ 
from that of saline-conditioned and extinguished controls that never acquired or 
extinguished morphine CPP. This series of comparisons indicates that the brain substrate 
underlying morphine CPP acquisition may include increased NAc core dendritic 
complexity, which is reduced after extinction, so that acquisition and extinction are 
opposite processes in brain and behavior. These findings provide some evidence that 
extinction may not be entirely new learning, but may also involve reversal of the original 
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learning, in this case, through reversal of morphological changes in neurons (Bouton, 2004; 
Vetere, et al., 2011; Mauk & Ohyama, 2004). 
 After acquisition, CPP score was correlated with two measures of NAc core 
dendritic complexity, specifically with dendritic length, and with number of intersections 
at many radii using the Sholl analysis. Another group was able to correlate cocaine CPP 
score with spine density in the NAc core and shell (Marie et al., 2012). Additionally, other 
paradigms have found learning to be associated with changes in neuron morphology 
(Comeau et al., 2010).  Acquisition of conditioned fear causes increased spine density and 
spine size in the anterior cingulate cortex, followed by a return to baseline spine density 
upon extinction, but persistent increase in spine size (Vetere, et al., 2011). This finding 
parallels ours in that there are opposite changes in acquisition and extinction. These 
findings supports the hypothesis that extinction of learned behavior may not be due to a 
completely new inhibitory pathway of new extinction learning, but that extinction may in 
part undo plasticity changes caused by acquisition of a behavior. It is possible that 
morphology changes that do persist despite extinction are responsible for reinstatement of 
extinguished behaviors. To study this question in the CPP model, future studies could 
examine morphology after reinstatement, and also look at neuron morphology in other 
brain regions to determine if CPP extinction globally or specifically reverses acquisition 
induced morphology changes. 
 Drug reward and exposure to drug-conditioned stimuli result in the delivery of 
dopamine from the VTA to the NAc, making dopamine transmission necessary for 
acquisition of morphine CPP (Kiefer & Dinter, 2013; Fenu et al., 2006). Dopamine is 
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probably also involved in morphine CPP extinction, since there is exposure to drug-
conditioned stimuli. We tested the role of dopamine in the extinction of morphine CPP, 
and on the associated dendritic morphology changes. It was already known that dopamine 
receptors play a role in morphine CPP acquisition, but their role in extinction had not 
previously been examined. From the current literature, it appears that the dopamine type 1 
receptor (D1R) plays the most important role in morphine CPP acquisition, so we focused 
on the type 1 receptor for our study (Acquas, Carboni, Leone, & Di Chiara, 1989; Fricks-
Gleason, Khalaj, & Marshall, 2012). We found that a 0.8 mg/kg dose of a D1 receptor 
agonist impeded morphine CPP extinction when it was given to mice after each extinction 
training session, while a lower 0.5 mg/kg dose had no effect on extinction. No previous 
studies looked at the effect of dopamine receptor blockade or agonism on morphine CPP 
extinction, but systemic D1R antagonism using SCH39166 injections after each extinction 
training session impaired extinction of cocaine CPP (Fricks-Gleason, et al., 2012). It is 
possible that any disruption of D1R activity can hinder CPP extinction, not just activation. 
When given before each extinction training session, a partial agonist of D1 receptors, 
SKF38393, facilitated extinction of cocaine CPP when injected into the prelimbic PFC 
(Brenhouse, Dumais, & Andersen, 2010). This finding highlights the importance of timing, 
so that activating the D1 receptor during or before extinction training may have different 
effects than activation after training. Also, since the above extinction studies were done 
using cocaine, the effects of dopamine may be different in our study because we used 
morphine, a different class of drug.  
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  Since extinction is thought to be the development of a new memory, it may be that 
the D1R agonist interfered with consolidation of the extinction memory in our study. 
Another study using the same SKF81297 D1R agonist that we used, but a much higher 5 
mg/kg dose, found that repeated systemic administration of the drug disrupted hippocampal 
LTP and the formation of new recognition type memories (Gangarossa, et al., 2014).  Intra-
hippocampal infusions of D1 antagonist SCH-23390 after training also disrupted 
consolidation of recognition type and avoidance type memories (Furini, Myskiw, Schmidt, 
Marcondes, & Izquierdo, 2014). Another possible explanation is that D1R agonism 
interferes with extinction by mimicking the drug reward induced by dopamine, and 
prevents the extinction memory from fully forming in the first place.  Normally, dopamine 
levels decrease during an extinction session, but we may have counteracted this effect by 
boosting D1R activation right at the end of extinction training when dopamine levels are 
normally lower (Ranaldi et al., 1999; Sunsay et al., 2014). 
Dopamine acting in the NAc, originating from the VTA, amplifies incentive 
salience (wanting), and therefore motivation for drugs (Di Chiara, 1999). Chronic use of 
opioids and other drugs of abuse hijacks this system and directly induces dopamine release, 
making drugs, and stimuli related to them, salient, imbuing them with the ability to 
motivate behavior. The system that is theorized to be responsible for generating drug 
seeking behavior in response to these drug-associated stimuli is the VTA-BLA-PFC-NAc 
core-VP circuit (Kalivas & Volkow, 2005). A possible explanation for why our findings 
were in the NAc core is that this region has a role of translating multiple streams of 
information into motivated motor behavior (Ito and Hayen, 2011). Dopamine released 
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during drug-cue associative learning may strengthen the connections between the PFC and 
NAc core drug seeking pathway. The PFC uses glutamate to signal to the NAc core, and 
dopamine can upregulate subunits of glutamate receptors in the post-synaptic membrane, 
enhancing synaptic signaling (Smith et al., 2005).  
 This research supports the idea of a neuron morphology brain substrate that 
involves increased NAc core dendritic complexity with the development of conditioned 
reward, and its reduction with the extinction of conditioned reward. The acquisition process 
is mediated by D1Rs since their activation enhances acquisition, and maintains CPP in the 
face of extinction training, possibly because the D1R activation maintains increased 
dendritic complexity in the NAc core.  
  Both morphine and the D1R agonist SKF81297 increased spine density of MSNs 
in the NAc core. Both of these drugs can be rewarding and induce CPP on their own. The 
increased spine density may make neurons more able to respond to surrounding stimuli by 
making more synapses available for input that is driven by stimuli coinciding with drug 
administration. 
 Our main findings (Figure 31) are that learning and drug effects combine during 
morphine CPP acquisition and lead to a specific increase in dendritic complexity in the 
NAc core. This increased dendritic complexity may reduce the excitability of NAc core 
neurons, which could make them able to activate more selectively to certain stimuli as way 
to discriminate the salient and non-salient environments that drive CPP behavior cite 
(Shepherd, 2008). After morphine CPP extinction, dendritic complexity is reduced in NAc 
core neurons. Oppositely, the reduced dendritic complexity seen after extinction may 
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increase the excitability of NAc neurons, so the neurons may lose their ability to be 
selectively activated by a specific environment, and therefore stop driving CPP behavior. 
Much previous research has implicated the D1R in morphine CPP acquisition, but did not 
test its role in extinction. In this study, the highest tested dose of D1R agonist SKF81297 
impeded extinction, and was associated with maintained increased dendritic complexity, 
which probably maintained the discriminating character of the NAc neurons, which 
continued to drive CPP behavior.  
 In summary, morphine CPP acquisition and extinction are opposite processes in 
brain and behavior, and D1R activation enhances and maintains acquisition, impeding 
extinction. Morphine CPP acquisition may be encoded by increased dendritic complexity 
of NAc core MSNs, while extinction may occur when these changes are reversed and 
dendritic complexity is reduced. These findings give us more insight into the brain 
substrates that control how drug reward conditioned behavior develops and diminishes. 
This research, past, and future studies can give us a deeper understanding of the 
motivational processes involved in drug addiction, and in cue exposure therapy. These 
findings in combination with those of other groups may provide future brain targets for 
treating addiction and for improving cue exposure therapy outcomes in particular.    
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Figure 31: Visual summary of NAc core neuron findings and their significance. Morphine 
and SKF81297 both increase spine density, making more synapses available to respond to 
input encoding stimuli that coincide with drug administration, contributing to the formation 
of drug reward conditioning. Morphine conditioned place preference associates a particular 
environment with morphine in juxtaposition to another environment that is explicitly not 
associated with morphine. The acquisition of CPP involves increased dendritic 
arborization, which decreases excitability of NAc neurons, and involves increased 
branching, which attenuates signal transmission. These morphological changes may work 
together to reduce overall excitability so that only specific inputs associated with the salient 
environment activate the neuron and lead to CPP behavior. Extinction explicitly pairs both 
environments with non-salient saline, thus making both environments not salient, and 
therefore, not differentiable in a meaningful way. Extinction is associated with decreased 
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dendritic complexity so that NAc core neurons are more excitable and less specific in their 
activation. Specific activation can stop because the previously morphine-associated 
chamber loses salience and therefore the NAc MSNs no longer needs to differentiate 
between the two CPP chambers. Giving D1R agonist after each extinction training 
probably maintains neuronal complexity because D1R activation increases dendritic 
arborization, opposing the extinction-induced reduction in arborization, and maintaining 
the discriminating abilities of the NAc core neuron.  
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